RGD DISEASE ONTOLOGY - ANNOTATIONS |
|
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
|
Term: | Fibrosis |
|
Accession: | DOID:9000784
|
browse the term
|
Definition: | Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury. |
Synonyms: | exact_synonym: | fibroses |
| primary_id: | MESH:D005355 |
For additional species annotation, visit the
Alliance of Genome Resources.
|
|
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31697999 |
|
NCBI chr 1:252,537,614...252,550,394
Ensembl chr 1:252,537,615...252,550,394
|
|
G |
Adcy5 |
adenylate cyclase 5 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:25193472 |
|
NCBI chr11:68,695,839...68,842,452
Ensembl chr11:68,695,839...68,842,320
|
|
G |
Adra2a |
adrenoceptor alpha 2A |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:20083574 |
|
NCBI chr 1:274,766,283...274,769,083
Ensembl chr 1:274,766,283...274,769,081
|
|
G |
Adra2c |
adrenoceptor alpha 2C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20083574 |
|
NCBI chr14:80,730,307...80,732,010
Ensembl chr14:80,730,307...80,732,010
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25193472 |
|
NCBI chr18:57,513,792...57,515,834
Ensembl chr18:57,513,793...57,515,834
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
|
IDA |
associated with Diabetes Mellitus, Experimental |
RGD |
PMID:12874465 |
RGD:1625346 |
NCBI chr20:4,363,152...4,366,079
Ensembl chr20:4,363,152...4,366,079
|
|
G |
Agt |
angiotensinogen |
|
IDA ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12414515 PMID:18785976 PMID:19373235 PMID:25398788 PMID:25807386 PMID:26648693, PMID:21367774 |
RGD:5129174 |
NCBI chr19:57,321,594...57,333,460
Ensembl chr19:57,321,640...57,333,433
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
|
IMP ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9596920, PMID:21367774 |
RGD:5129174 |
NCBI chr17:35,907,102...35,958,136
Ensembl chr17:35,907,108...35,958,077
|
|
G |
Agtr2 |
angiotensin II receptor, type 2 |
|
ISO IMP |
associated with Ureteral Obstruction associated with Hypertension |
RGD |
PMID:18327089, PMID:22184331 |
RGD:6903848, RGD:6903874 |
NCBI chr X:119,389,480...119,393,845
Ensembl chr X:119,390,013...119,393,842
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24448315 |
|
NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258
|
|
G |
Alb |
albumin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24309158 |
|
NCBI chr14:19,176,275...19,191,793
Ensembl chr14:19,176,277...19,191,863
|
|
G |
Angpt1 |
angiopoietin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18480750 PMID:18626492 |
|
NCBI chr 7:81,338,327...81,592,459
Ensembl chr 7:81,342,280...81,592,206
|
|
G |
Atm |
ATM serine/threonine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24358288 |
|
NCBI chr 8:58,015,938...58,119,973
Ensembl chr 8:58,015,940...58,120,045
|
|
G |
Atp6ap2 |
ATPase H+ transporting accessory protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21795644 |
|
NCBI chr X:11,137,889...11,164,854
Ensembl chr X:11,136,939...11,164,915
|
|
G |
Bdkrb1 |
bradykinin receptor B1 |
|
IMP |
|
RGD |
PMID:15253105 |
RGD:1625759 |
NCBI chr 6:129,437,423...129,441,553
Ensembl chr 6:129,438,158...129,440,574
|
|
G |
Bmp10 |
bone morphogenetic protein 10 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:31712309 |
|
NCBI chr 4:119,224,906...119,230,534
Ensembl chr 4:119,225,040...119,230,728
|
|
G |
Ca9 |
carbonic anhydrase 9 |
|
ISO |
associated with Breast Neoplasms;mRNA:increased expression:breast |
RGD |
PMID:18483361 |
RGD:2293190 |
NCBI chr 5:59,008,277...59,015,535
Ensembl chr 5:59,008,933...59,015,528
|
|
G |
Calr |
calreticulin |
disease_progression |
IEP |
associated with kidney disease; mRNA, protein:increased expression:kidney cortex |
RGD |
PMID:18563736 |
RGD:2326172 |
NCBI chr19:25,956,771...25,961,666
Ensembl chr19:25,956,771...25,961,666
|
|
G |
Ccl11 |
C-C motif chemokine ligand 11 |
|
IEP |
|
RGD |
PMID:20832583 |
RGD:4145471 |
NCBI chr10:69,434,965...69,439,566
Ensembl chr10:69,434,941...69,439,575
|
|
G |
Ccn2 |
cellular communication network factor 2 |
|
IEP IMP |
mRNA, protein:increased expression:kidney (rat) |
RGD |
PMID:19670084, PMID:18790236 |
RGD:2315507, RGD:2314612 |
NCBI chr 1:21,851,657...21,854,773
Ensembl chr 1:21,851,660...21,854,773
|
|
G |
Ccnd2 |
cyclin D2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16306446 |
|
NCBI chr 4:159,674,885...159,697,207
Ensembl chr 4:159,674,885...159,697,207
|
|
G |
Cd40lg |
CD40 ligand |
treatment |
ISO |
|
RGD |
PMID:17823201 |
RGD:8547759 |
NCBI chr X:159,703,703...159,714,886
Ensembl chr X:159,703,578...159,716,562
|
|
G |
Cdh1 |
cadherin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31697999 |
|
NCBI chr19:38,768,467...38,838,395
Ensembl chr19:38,768,467...38,838,395
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
IEP |
protein:decreased expression:renal tubule |
RGD |
PMID:16137007 |
RGD:2293625 |
NCBI chr 4:168,689,043...168,694,159
Ensembl chr 4:168,689,163...168,693,964
|
|
G |
Chrna1 |
cholinergic receptor nicotinic alpha 1 subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19690163 |
|
NCBI chr 3:60,445,657...60,460,724
Ensembl chr 3:60,445,666...60,460,724
|
|
G |
Col18a1 |
collagen type XVIII alpha 1 chain |
|
IEP |
mRNA:increased expression:liver |
RGD |
PMID:11592600 |
RGD:632362 |
NCBI chr20:12,225,202...12,332,858
Ensembl chr20:12,225,202...12,332,858
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20388698 |
|
NCBI chr10:82,745,801...82,762,790
Ensembl chr10:82,745,801...82,762,789
|
|
G |
Col1a2 |
collagen type I alpha 2 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20388698 |
|
NCBI chr 4:31,534,225...31,569,152
Ensembl chr 4:31,534,225...31,569,151
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20388698 |
|
NCBI chr 9:52,023,295...52,059,221
Ensembl chr 9:52,023,295...52,059,217
|
|
G |
Csf3 |
colony stimulating factor 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:18785976 PMID:20005281 |
|
NCBI chr10:86,616,785...86,619,160
Ensembl chr10:86,616,785...86,619,157
|
|
G |
Ctnnb1 |
catenin beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29394407 |
|
NCBI chr 8:129,601,511...129,628,378
Ensembl chr 8:129,617,812...129,627,372
|
|
G |
Cyp11b2 |
cytochrome P450, family 11, subfamily b, polypeptide 2 |
|
IEP |
protein:increased expression:liver (rat) |
RGD |
PMID:16938653 |
RGD:4891377 |
NCBI chr 7:116,248,759...116,255,205
Ensembl chr 7:116,156,219...116,255,167
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22028442 |
|
NCBI chr 8:58,744,849...58,772,408
Ensembl chr 8:58,744,849...58,772,408
|
|
G |
Dcn |
decorin |
|
IEP ISO |
mRNA:increased expression:kidney CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16005714, PMID:16005714 |
RGD:2311424 |
NCBI chr 7:38,742,250...38,782,282
Ensembl chr 7:38,742,051...38,782,323
|
|
G |
Fech |
ferrochelatase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10464147 |
|
NCBI chr18:59,941,992...59,975,192
Ensembl chr18:59,941,992...59,975,192
|
|
G |
Gata1 |
GATA binding protein 1 |
|
ISO |
|
RGD |
PMID:15665119 |
RGD:10450614 |
NCBI chr X:15,273,937...15,281,759
Ensembl chr X:15,378,789...15,382,066
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26042203 |
|
NCBI chr 7:12,516,357...12,519,154
Ensembl chr 7:12,516,352...12,519,154
|
|
G |
Hdac3 |
histone deacetylase 3 |
|
IEP |
protein:increased expression:penis: |
RGD |
PMID:24636283 |
RGD:9590194 |
NCBI chr18:31,073,057...31,094,347
Ensembl chr18:31,073,058...31,094,303
|
|
G |
Hdac4 |
histone deacetylase 4 |
|
IEP |
protein:increased expression:penis: |
RGD |
PMID:24636283 |
RGD:9590194 |
NCBI chr 9:99,052,945...99,299,715
Ensembl chr 9:99,057,089...99,299,715
|
|
G |
Hmox1 |
heme oxygenase 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:18784349 |
|
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
IEP |
mRNA, protein:increased expression:pancreas |
RGD |
PMID:22844569 |
RGD:8547732 |
NCBI chr 8:22,035,287...22,047,049
Ensembl chr 8:22,035,256...22,047,059
|
|
G |
Il13 |
interleukin 13 |
treatment |
IEP |
associated with Venous Thrombosis |
RGD |
PMID:12947342 |
RGD:8549644 |
NCBI chr10:38,982,909...38,985,466
Ensembl chr10:38,982,909...38,985,466
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:25388157 |
|
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:7637259 |
|
NCBI chr 3:1,449,778...1,468,624
Ensembl chr 3:1,452,644...1,468,614
|
|
G |
Il4 |
interleukin 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24286936, PMID:10486156 |
RGD:7829775 |
NCBI chr10:38,963,979...38,969,531
Ensembl chr10:38,963,979...38,969,531
|
|
G |
Klf5 |
Kruppel-like factor 5 |
severity |
ISO |
|
RGD |
PMID:15098654 |
RGD:1304323 |
NCBI chr15:83,703,796...83,722,921
Ensembl chr15:83,703,791...83,722,921
|
|
G |
Klk1 |
kallikrein 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:18227104 |
|
NCBI chr 1:100,131,562...100,135,556
Ensembl chr 1:100,059,967...100,203,329 Ensembl chr 1:100,059,967...100,203,329 Ensembl chr 1:100,059,967...100,203,329
|
|
G |
Lepr |
leptin receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20567778 PMID:29988851 |
|
NCBI chr 5:120,503,475...120,682,281
Ensembl chr 5:120,564,645...120,682,221
|
|
G |
Lgals3 |
galectin 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27870162 |
|
NCBI chr15:24,153,602...24,165,537
Ensembl chr15:24,141,651...24,165,537
|
|
G |
Lum |
lumican |
|
IEP |
mRNA:increased expression:liver associated with Pancreatitis;mRNA, protein:increased expression, altered localization:pancreas |
RGD |
PMID:1385211, PMID:12645630 |
RGD:2317695, RGD:724427 |
NCBI chr 7:38,820,058...38,826,862
Ensembl chr 7:38,819,771...38,826,862
|
|
G |
Map2k7 |
mitogen activated protein kinase kinase 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21284947 |
|
NCBI chr12:2,546,278...2,555,310
Ensembl chr12:2,548,218...2,555,164
|
|
G |
Mir133a1 |
microRNA 133a-1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:19893015 |
|
NCBI chr18:2,052,478...2,052,564
|
|
G |
Mir155 |
microRNA 155 |
|
ISO |
|
RGD |
PMID:28947593 |
RGD:21079432 |
NCBI chr11:24,176,603...24,176,667
Ensembl chr11:24,176,603...24,176,667
|
|
G |
Mir21 |
microRNA 21 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23469132 |
|
NCBI chr10:73,902,210...73,902,301
Ensembl chr10:73,902,210...73,902,301
|
|
G |
Mir217 |
microRNA 217 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26891083 |
|
NCBI chr14:113,119,529...113,119,633
Ensembl chr14:113,119,529...113,119,633
|
|
G |
Mir30d |
microRNA 30d |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31697999 |
|
NCBI chr 7:109,286,463...109,286,544
Ensembl chr 7:109,286,463...109,286,544
|
|
G |
Mir30e |
microRNA 30e |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31697999 |
|
NCBI chr 5:139,702,872...139,702,963
Ensembl chr 5:139,702,872...139,702,963
|
|
G |
Mirlet7f2 |
microRNA let-7f-2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31570982 |
|
NCBI chr X:21,583,272...21,583,354
Ensembl chr X:21,583,272...21,583,354
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
|
IEP |
protein:increased expression:liver |
RGD |
PMID:20108118 |
RGD:2325790 |
NCBI chr19:15,542,771...15,570,589
Ensembl chr19:15,542,765...15,570,611
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
IEP |
protein:increased expression:liver |
RGD |
PMID:20108118 |
RGD:2325790 |
NCBI chr 3:161,413,410...161,421,473
Ensembl chr 3:161,413,298...161,421,520
|
|
G |
Npr1 |
natriuretic peptide receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20881240 |
|
NCBI chr 2:189,840,403...189,857,032
Ensembl chr 2:189,840,403...189,856,090
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
ISO |
associated with Ureteral Obstruction |
RGD |
PMID:21613422 |
RGD:5683902 |
NCBI chr13:98,857,255...98,889,444
Ensembl chr13:98,857,177...98,889,716
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22004089, PMID:17195235, PMID:11780721, PMID:8644858 |
RGD:6482660, RGD:6482691, RGD:6482673 |
NCBI chr 7:121,215,458...121,233,092
Ensembl chr 7:121,214,628...121,232,741
|
|
G |
Pdgfd |
platelet derived growth factor D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25280005 |
|
NCBI chr 8:4,441,010...4,666,754
Ensembl chr 8:4,440,876...4,669,014
|
|
G |
Phb |
prohibitin |
|
ISO |
associated with Glomerulonephritis;protein:decreased expression:kidney, epithelial cell |
RGD |
PMID:17043753 |
RGD:2292410 |
NCBI chr10:83,476,107...83,488,878
Ensembl chr10:83,476,107...83,488,878
|
|
G |
Phkg2 |
phosphorylase kinase catalytic subunit gamma 2 |
|
ISO |
associated with Glycogen Storage Disease Type Ix;DNA:mutations:multiple (human) |
RGD |
PMID:9384616 |
RGD:737725 |
NCBI chr 1:199,019,298...199,032,053
Ensembl chr 1:199,019,289...199,032,052
|
|
G |
Phox2a |
paired-like homeobox 2a |
|
ISO |
|
RGD |
PMID:11600883 |
RGD:1599902 |
NCBI chr 1:166,893,734...166,898,252
Ensembl chr 1:166,893,734...166,898,252
|
|
G |
Pik3cg |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
|
IMP ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12963636, PMID:21866628 |
RGD:6482708 |
NCBI chr 6:51,465,696...51,501,234
Ensembl chr 6:51,465,908...51,498,337
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
IMP ISO |
associated with Hypertension |
RGD |
PMID:18360056, PMID:18511847 |
RGD:2301893, RGD:2301856 |
NCBI chr 4:147,274,055...147,399,383
Ensembl chr 4:147,274,107...147,399,380
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
IMP ISO |
associated with Cholestasis CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11872629, PMID:18462380 |
RGD:2300279 |
NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
|
|
G |
Ren |
renin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12414515 |
|
NCBI chr13:50,502,724...50,513,953
Ensembl chr13:50,502,724...50,514,151
|
|
G |
Rhoa |
ras homolog family member A |
|
IEP |
associated with Hypertension;protein:increased activation:heart |
RGD |
PMID:17184496 |
RGD:1642810 |
NCBI chr 8:117,082,440...117,116,244
Ensembl chr 8:117,106,576...117,116,167
|
|
G |
Sfrp1 |
secreted frizzled-related protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30377735 |
|
NCBI chr16:73,372,007...73,410,777
Ensembl chr16:73,372,007...73,410,777
|
|
G |
Sirt1 |
sirtuin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20651248 |
|
NCBI chr20:26,831,971...26,851,587
Ensembl chr20:26,833,357...26,852,199
|
|
G |
Slc27a2 |
solute carrier family 27 member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28871336 |
|
NCBI chr 3:119,014,620...119,052,531
Ensembl chr 3:119,014,620...119,052,531
|
|
G |
Socs3 |
suppressor of cytokine signaling 3 |
|
IEP |
|
RGD |
PMID:16012948 |
RGD:1625686 |
NCBI chr10:106,973,863...106,976,969
Ensembl chr10:106,975,178...106,976,040
|
|
G |
Sod2 |
superoxide dismutase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19293248 |
|
NCBI chr 1:47,914,757...47,921,587
Ensembl chr 1:47,914,759...47,921,587
|
|
G |
Sod3 |
superoxide dismutase 3 |
|
ISO |
|
RGD |
PMID:11880297 |
RGD:1581266 |
NCBI chr14:60,958,583...60,971,143
Ensembl chr14:60,958,592...60,964,324
|
|
G |
Sphk1 |
sphingosine kinase 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:19657322 |
|
NCBI chr10:105,498,728...105,504,401
Ensembl chr10:105,498,728...105,504,393
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
|
ISO |
|
RGD |
PMID:15123578 |
RGD:1581343 |
NCBI chr14:6,673,686...6,679,965
Ensembl chr14:6,673,686...6,679,901
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24448315 |
|
NCBI chr10:88,790,401...88,842,263
Ensembl chr10:88,790,408...88,842,233
|
|
G |
Stat6 |
signal transducer and activator of transcription 6 |
|
ISO |
|
RGD |
PMID:10486156 |
RGD:7829775 |
NCBI chr 7:70,946,228...70,963,542
Ensembl chr 7:70,946,228...70,964,484
|
|
G |
Tac1 |
tachykinin, precursor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28647476 |
|
NCBI chr 4:33,638,853...33,646,819
Ensembl chr 4:33,638,709...33,646,819
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
|
ISO IMP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10469268 PMID:16306446 PMID:17947678 PMID:18705752 PMID:24142982 PMID:26054450 PMID:27870162 PMID:30809271, PMID:9389733, PMID:26923362, PMID:2054795 |
RGD:737732, RGD:11073665, RGD:7394820 |
NCBI chr 1:82,480,875...82,497,196
Ensembl chr 1:82,480,195...82,497,199
|
|
G |
Thbs1 |
thrombospondin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16005714 |
|
NCBI chr 3:109,862,120...109,873,466
Ensembl chr 3:109,862,117...109,873,466
|
|
G |
Thg1l |
tRNA-histidine guanylyltransferase 1-like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21784897 |
|
NCBI chr10:31,043,647...31,052,092
Ensembl chr10:31,043,688...31,052,102
|
|
G |
Tlr4 |
toll-like receptor 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27585667 |
|
NCBI chr 5:82,587,424...82,601,056
Ensembl chr 5:82,587,420...82,601,052
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18034274 |
|
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
|
|
G |
Tph1 |
tryptophan hydroxylase 1 |
|
ISO |
|
RGD |
PMID:21518801 |
RGD:5686344 |
NCBI chr 1:102,669,868...102,699,442
Ensembl chr 1:102,669,868...102,699,442
|
|
G |
Vim |
vimentin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31697999 |
|
NCBI chr17:80,882,715...80,891,200
Ensembl chr17:80,882,666...80,891,212
|
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
susceptibility |
ISO |
DNA:missense mutation:cds:p.E504K (human) DNA:missense mutation:cds: (rs671) (human) associated with alcohol dependence;DNA:missense mutation:exon 12:p.E487K (human) |
RGD |
PMID:29779728, PMID:23550892, PMID:11051375 |
RGD:14696777, RGD:15042864, RGD:15042858 |
NCBI chr12:40,466,418...40,498,813
Ensembl chr12:40,466,495...40,498,752
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23274713 |
|
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
|
|
G |
Cat |
catalase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23274713 |
|
NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
|
|
G |
Cnp |
2',3'-cyclic nucleotide 3' phosphodiesterase |
|
ISO |
protein:decreased expression:brain |
RGD |
PMID:16205370 |
RGD:6483345 |
NCBI chr10:88,490,798...88,497,357
Ensembl chr10:88,490,798...88,497,356
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23274713 |
|
NCBI chr 9:52,023,295...52,059,221
Ensembl chr 9:52,023,295...52,059,217
|
|
G |
Crp |
C-reactive protein |
severity |
ISO |
|
RGD |
PMID:22441510 |
RGD:6482305 |
NCBI chr13:91,080,448...91,081,358
Ensembl chr13:91,054,974...91,093,713
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20843640, PMID:29404441 |
RGD:14700873 |
NCBI chr 1:213,511,892...213,522,195
Ensembl chr 1:213,511,874...213,535,542
|
|
G |
Fabp2 |
fatty acid binding protein 2 |
onset |
ISO |
DNA:polymorphism:CDS:amino acid A54T, homozygosity of the T allele associated with later onset |
RGD |
PMID:16289894, PMID:16289894 |
RGD:1578455, RGD:1578455 |
NCBI chr 2:227,080,912...227,083,654
Ensembl chr 2:227,080,924...227,083,501
|
|
G |
Il18bp |
interleukin 18 binding protein |
|
ISO |
protein:increased expression:plasma: |
RGD |
PMID:15566508 |
RGD:14696666 |
NCBI chr 1:167,091,521...167,095,727
Ensembl chr 1:167,091,522...167,093,560
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23274713 |
|
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
|
|
G |
Jak2 |
Janus kinase 2 |
|
ISO |
mRNA, protein:increased expression, increased tyrosine phosphorylation:liver |
RGD |
PMID:24619965 |
RGD:10403061 |
NCBI chr 1:247,398,667...247,457,521
Ensembl chr 1:247,398,598...247,458,509
|
|
G |
Lep |
leptin |
|
IDA |
DNA:hypomethylation:promoter (human) |
RGD |
PMID:29912265 |
RGD:21201248 |
NCBI chr 4:56,337,695...56,351,818
Ensembl chr 4:56,337,695...56,351,818
|
|
G |
Mboat7 |
membrane bound O-acyltransferase domain containing 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26482880 |
|
NCBI chr 1:64,100,159...64,114,437
Ensembl chr 1:64,101,018...64,113,792
|
|
G |
Mir122 |
microRNA 122 |
|
ISO |
miRNA:decreased expression:liver |
RGD |
PMID:28987423 |
RGD:14401600 |
NCBI chr18:60,755,285...60,755,369
|
|
G |
Mir141 |
microRNA 141 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr 4:157,236,346...157,236,439
Ensembl chr 4:157,236,346...157,236,439
|
|
G |
Mir17 |
microRNA 17 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr15:100,179,879...100,179,962
Ensembl chr15:100,179,879...100,179,962
|
|
G |
Mir193b |
microRNA 193b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr14:30,331,049...30,331,131
Ensembl chr14:30,331,049...30,331,131
|
|
G |
Mir423 |
microRNA 423 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr10:63,098,366...63,098,444
Ensembl chr10:63,098,360...63,098,453
|
|
G |
Mir484 |
microRNA 484 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr10:27,845...27,921
Ensembl chr10:27,845...27,921
|
|
G |
Mir532 |
microRNA 532 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr X:16,109,870...16,109,948
Ensembl chr X:16,109,870...16,109,948
|
|
G |
Mir93 |
microRNA 93 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr12:19,307,543...19,307,629
Ensembl chr12:19,307,543...19,307,629
|
|
G |
Mmp13 |
matrix metallopeptidase 13 |
|
IEP |
|
RGD |
PMID:16286264 |
RGD:10043176 |
NCBI chr 8:5,522,739...5,533,018
Ensembl chr 8:5,522,739...5,533,018
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23274713 |
|
NCBI chr19:15,542,771...15,570,589
Ensembl chr19:15,542,765...15,570,611
|
|
G |
Mpo |
myeloperoxidase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19731237 PMID:23274713 |
|
NCBI chr10:75,087,892...75,098,260
Ensembl chr10:75,087,892...75,098,260
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
susceptibility |
ISO |
DNA:SNP: :677C>T(human) |
RGD |
PMID:25987440 |
RGD:14696749 |
NCBI chr 5:164,844,642...164,864,360
Ensembl chr 5:164,845,925...164,860,910
|
|
G |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
|
ISO |
|
RGD |
PMID:24497272 |
RGD:10448995 |
NCBI chr10:86,683,875...86,690,815
Ensembl chr10:86,683,875...86,690,815
|
|
G |
Plau |
plasminogen activator, urokinase |
|
IDA |
|
RGD |
PMID:19615318 |
RGD:7241800 |
NCBI chr15:3,644,296...3,650,765
Ensembl chr15:3,644,769...3,650,819
|
|
G |
Pnpla3 |
patatin-like phospholipase domain containing 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19946271 PMID:26482880 |
|
NCBI chr 7:125,034,760...125,056,165
Ensembl chr 7:125,034,764...125,055,976
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23274713 |
|
NCBI chr 1:220,992,770...221,003,249
Ensembl chr 1:220,992,770...221,003,249
|
|
G |
Serpine1 |
serpin family E member 1 |
susceptibility |
ISO |
DNA:polymorphism:promoter: |
RGD |
PMID:25987440 |
RGD:14696749 |
NCBI chr12:22,641,104...22,651,482
Ensembl chr12:22,641,104...22,651,482
|
|
G |
Serpinf1 |
serpin family F member 1 |
|
ISO |
protein:increased expression:serum (human) |
RGD |
PMID:27748324 |
RGD:27226704 |
NCBI chr10:62,241,750...62,254,145
Ensembl chr10:62,241,756...62,254,287
|
|
G |
Smad3 |
SMAD family member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23274713 |
|
NCBI chr 8:68,569,530...68,678,349
Ensembl chr 8:68,569,530...68,678,349
|
|
G |
Sod2 |
superoxide dismutase 2 |
susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism DNA:SNP: : 47T>C(human) |
CTD |
PMID:19731237, PMID:26873981 |
RGD:11060603 |
NCBI chr 1:47,914,757...47,921,587
Ensembl chr 1:47,914,759...47,921,587
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23274713 |
|
NCBI chr 1:82,480,875...82,497,196
Ensembl chr 1:82,480,195...82,497,199
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23274713 |
|
NCBI chr X:1,364,771...1,369,451
Ensembl chr X:1,364,786...1,369,384
|
|
G |
Tlr9 |
toll-like receptor 9 |
|
ISO |
protein:increased expression:blood, neutrophil (human) |
RGD |
PMID:18433921 |
RGD:5130706 |
NCBI chr 8:114,916,122...114,920,171
Ensembl chr 8:114,916,122...114,920,171
|
|
G |
Tm6sf2 |
transmembrane 6 superfamily member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26482880 |
|
NCBI chr16:21,092,483...21,099,695
Ensembl chr16:21,092,308...21,099,878
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23274713 |
|
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
|
|
|
G |
Aqp4 |
aquaporin 4 |
|
ISO |
|
RGD |
PMID:20680636 |
RGD:5148026 |
NCBI chr18:6,766,009...6,782,757
Ensembl chr18:6,765,945...6,782,996
|
|
G |
Edar |
ectodysplasin-A receptor |
|
ISO |
ClinVar Annotator: match by term: Progressive sclerosing poliodystrophy |
ClinVar |
PMID:10431241 PMID:18231121 PMID:20236127 PMID:20979233 PMID:25741868 PMID:28492532 |
|
NCBI chr20:28,179,132...28,263,092
Ensembl chr20:28,179,140...28,263,037
|
|
G |
Fanci |
FA complementation group I |
|
ISO |
ClinVar Annotator: match by term: Mitochondrial DNA depletion syndrome 4A (Alpers type) ClinVar Annotator: match by term: Progressive sclerosing poliodystrophy |
ClinVar |
PMID:15477547 PMID:16177225 PMID:17088268 PMID:17426723 PMID:17438011 PMID:17950645 PMID:17980715 PMID:18414213 PMID:18991199 PMID:19010300 PMID:20691285 PMID:21038416 PMID:21228398 PMID:21880868 PMID:23524600 PMID:23783014 PMID:24033266 PMID:25462018 PMID:25741868 PMID:26104464 PMID:26467025 PMID:27987238 PMID:28492532 |
|
NCBI chr 1:141,116,565...141,172,997
Ensembl chr 1:141,120,166...141,172,483
|
|
G |
Polg |
DNA polymerase gamma, catalytic subunit |
susceptibility |
ISO IAGP |
DNA:mutations:cds: ClinVar Annotator: match by term: Progressive sclerosing poliodystrophy ClinVar Annotator: match by term: Neuronal degeneration of childhood with liver disease, progressive DNA:missense mutation:cds:p.P1073L (3218C>T) (human) CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Mitochondrial DNA depletion syndrome 4A (Alpers type) DNA:missense mutations:cds: |
ClinVar CTD OMIM |
PMID:632821 PMID:1582434 PMID:2067633 PMID:2725645 PMID:8884268 PMID:9500334 PMID:11431686 PMID:11571332 PMID:11897778 PMID:12073019 PMID:12210792 PMID:12297582 PMID:12565911 PMID:12707443 PMID:12825077 PMID:12872260 PMID:12975295 PMID:14467368 PMID:14557557 PMID:14635118 PMID:14694057 PMID:14745080 PMID:15122711 PMID:15181170 PMID:15258572 PMID:15349879 PMID:15351195 PMID:15477547 PMID:15534189 PMID:15689359 PMID:15800909 PMID:15824347 PMID:15913923 PMID:15917273 PMID:15929042 PMID:16024923 PMID:16080118 PMID:16130100 PMID:16177225 PMID:16368709 PMID:16401742 PMID:16545482 PMID:16621917 PMID:16634032 PMID:16638794 PMID:16639411 PMID:16715201 PMID:16857757 PMID:16919951 PMID:16929381 PMID:16940310 PMID:16943369 PMID:16957900 PMID:17067213 PMID:17088268 PMID:17280874 PMID:17426723 PMID:17436221 PMID:17438011 PMID:17452231 PMID:17502560 PMID:17538929 PMID:17846414 PMID:17894835 PMID:17923349 PMID:17950645 PMID:17980715 PMID:18156159 PMID:18195149 PMID:18195151 PMID:18294203 PMID:18321754 PMID:18414213 PMID:18487244 PMID:18500570 PMID:18546343 PMID:18546365 PMID:18585914 PMID:18716558 PMID:18783964 PMID:18828154 PMID:18991199 PMID:19010300 PMID:19103152 PMID:19125351 PMID:19189930 PMID:19195941 PMID:19251978 PMID:19275594 PMID:19307547 PMID:19344718 PMID:19364868 PMID:19478085 PMID:19501198 PMID:19538466 PMID:19566497 PMID:19578034 PMID:19629138 PMID:19752458 PMID:19762913 PMID:19766516 PMID:19813183 PMID:19815814 PMID:19837034 PMID:19862739 PMID:20138553 PMID:20142534 PMID:20153822 PMID:20176107 PMID:20185557 PMID:20227526 PMID:20301791 PMID:20385918 PMID:20434700 PMID:20438629 PMID:20513108 PMID:20576279 PMID:20601675 PMID:20691285 PMID:20701905 PMID:20803511 PMID:20818383 PMID:20837861 PMID:20837862 PMID:20843780 PMID:20883824 PMID:20981092 PMID:21038416 PMID:21138766 PMID:21228000 PMID:21228398 PMID:21235791 PMID:21236670 PMID:21259344 PMID:21276947 PMID:21282586 PMID:21301859 PMID:21305355 PMID:21357833 PMID:21455106 PMID:21515089 PMID:21550804 PMID:21647632 PMID:21654874 PMID:21670405 PMID:21686371 PMID:21696159 PMID:21704543 PMID:21824913 PMID:21856450 PMID:21880868 PMID:21953457 PMID:21956653 PMID:21993618 PMID:22000311 PMID:22006280 PMID:22114710 PMID:22166854 PMID:22189570 PMID:22237560 PMID:22277967 PMID:22334187 PMID:22342071 PMID:22357363 PMID:22470557 PMID:22494076 PMID:22552686 PMID:22616202 PMID:22647225 PMID:22711370 PMID:22727047 PMID:22778364 PMID:22863191 PMID:22931735 PMID:22933815 PMID:22987704 PMID:22995991 PMID:23066759 PMID:23077218 PMID:23084792 PMID:23208208 PMID:23212759 PMID:23248042 PMID:23250882 PMID:23251356 PMID:23299917 PMID:23324391 PMID:23426270 PMID:23430834 PMID:23446635 PMID:23446645 PMID:23448099 PMID:23524600 PMID:23545419 PMID:23665194 PMID:23719791 PMID:23783014 PMID:23804100 PMID:23808377 PMID:23811324 PMID:23873972 PMID:23921535 PMID:24033266 PMID:24091540 PMID:24099403 PMID:24122062 PMID:24259288 PMID:24265579 PMID:24272679 PMID:24288107 PMID:24331360 PMID:24508722 PMID:24642831 PMID:24725338 PMID:24841123 PMID:25025039 PMID:25065347 PMID:25118206 PMID:25203713 PMID:25281868 PMID:25286830 PMID:25356970 PMID:25462018 PMID:25466440 PMID:25488682 PMID:25585994 PMID:25660390 PMID:25713120 PMID:25741868 PMID:25771874 PMID:25850945 PMID:25914719 PMID:25940035 PMID:26050231 PMID:26077851 PMID:26095671 PMID:26104464 PMID:26169155 PMID:26337858 PMID:26357557 PMID:26467025 PMID:26468652 PMID:26557169 PMID:26607151 PMID:26735972 PMID:26755490 PMID:26942291 PMID:26942292 PMID:26968897 PMID:27016405 PMID:27119776 PMID:27185166 PMID:27271921 PMID:27290639 PMID:27345795 PMID:27381400 PMID:27422324 PMID:27450679 PMID:27538604 PMID:27538665 PMID:27822509 PMID:27826120 PMID:27838477 PMID:27987238 PMID:28128857 PMID:28130605 PMID:28154168 PMID:28206745 PMID:28284481 PMID:28337550 PMID:28471437 PMID:28480171 PMID:28492532 PMID:28634151 PMID:28771251 PMID:28776642 PMID:28812649 PMID:28837072 PMID:28865037 PMID:28901595 PMID:28958595 PMID:29029963 PMID:29190809 PMID:29272804 PMID:29278894 PMID:29302508 PMID:29341116 PMID:29358615 PMID:29423831 PMID:29474836 PMID:29482223 PMID:29574624 PMID:29588995 PMID:29644085 PMID:29712893 PMID:29915382 PMID:29920680 PMID:29950568 PMID:29992832 PMID:30021052 PMID:30167885 PMID:30255931 PMID:30290626 PMID:30373890 PMID:30423451 PMID:30831263 PMID:30843307, PMID:15689359, PMID:20142534, PMID:16896309, PMID:22237560 |
RGD:8694184, RGD:15039298, RGD:8694317, RGD:8694284 |
NCBI chr 1:141,172,117...141,188,893
Ensembl chr 1:141,172,531...141,188,031
|
|
G |
Rlbp1 |
retinaldehyde binding protein 1 |
|
ISO |
ClinVar Annotator: match by term: Progressive sclerosing poliodystrophy |
ClinVar |
|
|
NCBI chr 1:141,097,789...141,111,375
Ensembl chr 1:141,097,695...141,111,400
|
|
|
G |
Ace |
angiotensin I converting enzyme |
|
ISO |
protein:increased expression:serum (human) |
RGD |
PMID:21290180 |
RGD:25671452 |
NCBI chr10:94,170,766...94,213,831
Ensembl chr10:94,170,766...94,187,822
|
|
G |
Itgb3 |
integrin subunit beta 3 |
|
ISO |
DNA:missense mutation: :p.L33P (human) |
RGD |
PMID:18685811 |
RGD:10755472 |
NCBI chr10:92,667,869...92,783,413
Ensembl chr10:92,667,869...92,783,410
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
susceptibility |
ISO |
DNA:SNPs: :DNA:SNPs: :677C>T, 1298A>C(human) |
RGD |
PMID:18685811 |
RGD:10755472 |
NCBI chr 5:164,844,642...164,864,360
Ensembl chr 5:164,845,925...164,860,910
|
|
G |
Serpine1 |
serpin family E member 1 |
susceptibility |
ISO |
DNA:polymorphism:promoter: |
RGD |
PMID:18685811 |
RGD:10755472 |
NCBI chr12:22,641,104...22,651,482
Ensembl chr12:22,641,104...22,651,482
|
|
|
G |
Ace2 |
angiotensin I converting enzyme 2 |
treatment |
IEP |
associated with Hypertension |
RGD |
PMID:21148624 |
RGD:9685434 |
NCBI chr X:32,050,734...32,095,860
Ensembl chr X:32,049,931...32,096,016
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
treatment |
IEP |
associated with Diabetes Mellitus, Experimental; protein:increased expression:cardiac atrium (rat) |
RGD |
PMID:21802905, PMID:24630381 |
RGD:7245957, RGD:8696003 |
NCBI chr20:4,363,152...4,366,079
Ensembl chr20:4,363,152...4,366,079
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
treatment |
IEP IDA |
associated with Hypertension;mRNA:increased expression:heart |
RGD |
PMID:21769867, PMID:19019833 |
RGD:5688337, RGD:8552780 |
NCBI chr10:82,745,801...82,762,790
Ensembl chr10:82,745,801...82,762,789
|
|
G |
Csf3 |
colony stimulating factor 3 |
|
ISO |
associated with Myocardial Infarction; |
RGD |
PMID:18676396 |
RGD:11039480 |
NCBI chr10:86,616,785...86,619,160
Ensembl chr10:86,616,785...86,619,157
|
|
G |
Dmd |
dystrophin |
|
IMP |
|
RGD |
PMID:25310701 |
RGD:12880034 |
NCBI chr X:51,149,358...53,519,271
Ensembl chr X:51,286,737...53,519,259
|
|
G |
Dmdem1Ang |
dystrophin; TALEN-induced mutant1, Ang |
|
IMP |
|
RGD |
PMID:25310701 |
RGD:12880034 |
|
|
G |
Edn1 |
endothelin 1 |
treatment |
IDA |
|
RGD |
PMID:11430925 |
RGD:8662299 |
NCBI chr17:22,136,814...22,143,745
Ensembl chr17:22,137,324...22,143,324
|
|
G |
F3 |
coagulation factor III, tissue factor |
|
ISO |
|
RGD |
PMID:12426405 |
RGD:11341691 |
NCBI chr 2:225,310,686...225,322,281
Ensembl chr 2:225,310,624...225,322,272
|
|
G |
Fbn1 |
fibrillin 1 |
|
IEP |
associated with Hypertension;protein:increased expression:myocardium |
RGD |
PMID:15849235 |
RGD:1601147 |
NCBI chr 3:117,569,708...117,766,160
Ensembl chr 3:117,569,697...117,766,120
|
|
G |
Fn1 |
fibronectin 1 |
|
IEP |
mRNA, protein:increased expression:heart: |
RGD |
PMID:23383330 |
RGD:10402158 |
NCBI chr 9:78,900,111...78,969,018
Ensembl chr 9:78,900,103...78,969,078
|
|
G |
Ghrl |
ghrelin and obestatin prepropeptide |
disease_progression treatment |
IEP ISO |
mRNA,protein:increased expression:plasma,myocardia: |
RGD |
PMID:16626506, PMID:16626506 |
RGD:12907503, RGD:12907503 |
NCBI chr 4:145,674,157...145,678,066
Ensembl chr 4:145,674,157...145,678,066
|
|
G |
Ghsr |
growth hormone secretagogue receptor |
|
IEP |
mRNA,protein:increased expression,increased activity:myocardia: |
RGD |
PMID:16626506 |
RGD:12907503 |
NCBI chr 2:113,065,953...113,071,265
Ensembl chr 2:113,066,885...113,070,261
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
|
IEP |
protein:decreased expression:myocardium |
RGD |
PMID:23906405 |
RGD:8662459 |
NCBI chr20:37,876,650...37,889,097
Ensembl chr20:37,876,650...37,889,089
|
|
G |
Hrc |
histidine rich calcium binding protein |
severity |
ISO |
associated with Heart Failure |
RGD |
PMID:22952658 |
RGD:9685495 |
NCBI chr 1:101,324,788...101,328,391
Ensembl chr 1:101,324,652...101,328,435
|
|
G |
Mfn2 |
mitofusin 2 |
|
IEP |
protein:decreased expression:heart (rat) |
RGD |
PMID:26692091 |
RGD:11557238 |
NCBI chr 5:164,684,244...164,715,414
Ensembl chr 5:164,684,509...164,714,145
|
|
G |
Mir221 |
microRNA 221 |
severity |
ISO |
associated with dilated cardiomyopathy; |
RGD |
PMID:29255073 |
RGD:18337269 |
NCBI chr X:3,684,480...3,684,588
Ensembl chr X:3,684,480...3,684,588
|
|
G |
Mir223 |
microRNA 223 |
treatment |
IMP |
associated with acute myocardial infarction; |
RGD |
PMID:29689569 |
RGD:25823140 |
NCBI chr X:65,367,812...65,367,921
Ensembl chr X:65,367,812...65,367,921
|
|
G |
Mir433 |
microRNA 433 |
treatment |
ISO |
associated with myocardial infarction |
RGD |
PMID:27698941, PMID:27698941 |
RGD:14700802, RGD:14700802 |
NCBI chr 6:133,712,334...133,712,426
Ensembl chr 6:133,712,334...133,712,426
|
|
G |
Mmp7 |
matrix metallopeptidase 7 |
|
IEP |
associated with Heart Failure |
RGD |
PMID:12875773 |
RGD:9685341 |
NCBI chr 8:5,893,253...5,900,965
Ensembl chr 8:5,893,249...5,901,049
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO IEP |
associated with Cardiomegaly;mRNA:increased expression:heart associated with Arthritis, Experimental |
RGD |
PMID:23144938, PMID:23905389 |
RGD:13204817, RGD:13204857 |
NCBI chr 3:161,413,410...161,421,473
Ensembl chr 3:161,413,298...161,421,520
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
treatment |
IEP |
associated with Hypertension |
RGD |
PMID:20231522 |
RGD:10413875 |
NCBI chr 6:76,267,227...76,270,457
Ensembl chr 6:76,267,228...76,270,457
|
|
G |
Nod1 |
nucleotide-binding oligomerization domain containing 1 |
|
ISO |
|
RGD |
PMID:23028889 |
RGD:9831166 |
NCBI chr 4:85,123,965...85,175,206
Ensembl chr 4:85,123,960...85,174,951
|
|
G |
Pak1 |
p21 (RAC1) activated kinase 1 |
|
ISO |
|
RGD |
PMID:22082674 |
RGD:11533929 |
NCBI chr 1:162,768,156...162,883,356
Ensembl chr 1:162,768,156...162,883,355
|
|
G |
Plekha7 |
pleckstrin homology domain containing A7 |
|
IMP |
|
RGD |
PMID:25136115 |
RGD:11079199 |
NCBI chr 1:185,427,600...185,493,985
Ensembl chr 1:185,356,975...185,538,694
|
|
G |
Plekha7em4Mcwi |
pleckstrin homology domain containing, family A member 7; zinc finger nuclease induced mutant 4, Medical College of Wisconsin |
|
IMP |
|
RGD |
PMID:25136115 |
RGD:11079199 |
|
|
G |
Serpine1 |
serpin family E member 1 |
treatment |
IEP IDA |
associated with Hypertension;mRNA, protein:increased expression:heart left ventricle (rat) associated with Metabolic Syndrome X |
RGD |
PMID:11961044, PMID:15604340 |
RGD:8547914, RGD:8547923 |
NCBI chr12:22,641,104...22,651,482
Ensembl chr12:22,641,104...22,651,482
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
|
ISO IEP |
protein:increased expression:heart: |
RGD |
PMID:22134166, PMID:27108788 |
RGD:11073617, RGD:11073667 |
NCBI chr 1:82,480,875...82,497,196
Ensembl chr 1:82,480,195...82,497,199
|
|
|
G |
Cd40lg |
CD40 ligand |
treatment |
IDA |
|
RGD |
PMID:23820408 |
RGD:11352285 |
NCBI chr X:159,703,703...159,714,886
Ensembl chr X:159,703,578...159,716,562
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
|
IEP |
|
RGD |
PMID:22576464 |
RGD:10401932 |
NCBI chr 1:219,291,679...219,294,147
Ensembl chr 1:219,291,679...219,294,147
|
|
G |
Idh1 |
isocitrate dehydrogenase (NADP(+)) 1 |
severity |
ISO |
associated with intrahepatic cholangiocarcinoma; DNA:missense mutations:cds:p. R132C, R132G, and R132L (human) |
RGD |
PMID:31121195 |
RGD:14974230 |
NCBI chr 9:71,882,108...71,911,645
Ensembl chr 9:71,882,105...71,900,044
|
|
|
G |
Col7a1 |
collagen type VII alpha 1 chain |
|
ISO |
ClinVar Annotator: match by term: Scarring |
ClinVar |
PMID:12787275 PMID:22266148 PMID:25741868 PMID:28492532 PMID:28830826 PMID:32860008 |
|
NCBI chr 8:117,694,441...117,726,844
Ensembl chr 8:117,694,605...117,726,844
|
|
G |
Mfn2 |
mitofusin 2 |
|
ISO |
ClinVar Annotator: match by term: Scarring |
ClinVar |
PMID:15064763 PMID:16437557 PMID:16714318 PMID:16835246 PMID:17296794 PMID:19889647 PMID:21285398 PMID:22442078 PMID:24126688 PMID:24604904 PMID:24862862 PMID:24863639 PMID:25025039 PMID:25326637 PMID:25741868 PMID:26085578 PMID:26382835 PMID:26467025 PMID:26686600 PMID:26801520 PMID:27549087 PMID:27863451 PMID:28492532 PMID:31188717 |
|
NCBI chr 5:164,684,244...164,715,414
Ensembl chr 5:164,684,509...164,714,145
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
treatment |
IDA |
associated with Wounds, Penetrating |
RGD |
PMID:23076999 |
RGD:13207326 |
NCBI chr 3:161,413,410...161,421,473
Ensembl chr 3:161,413,298...161,421,520
|
|
G |
Smad4 |
SMAD family member 4 |
treatment |
IMP |
|
RGD |
PMID:21255090 |
RGD:12880045 |
NCBI chr18:69,626,682...69,657,373
Ensembl chr18:69,627,757...69,671,199
|
|
|
G |
Kif21a |
kinesin family member 21A |
|
ISO |
DNA:missense mutation:CDS:2860C>T (p.R954W) (human) ClinVar Annotator: match by term: Fibrosis of extraocular muscles, congenital, 1 |
ClinVar OMIM |
PMID:14595441 PMID:15621876 PMID:15621877 PMID:15827546 PMID:18332320 PMID:19551685 PMID:25741868 PMID:28492532, PMID:14595441 |
RGD:1600402 |
NCBI chr 7:132,069,962...132,200,947
Ensembl chr 7:132,071,116...132,143,470
|
|
|
G |
Phox2a |
paired-like homeobox 2a |
|
ISO |
ClinVar Annotator: match by OMIM:602078 |
OMIM ClinVar |
PMID:11600883 |
|
NCBI chr 1:166,893,734...166,898,252
Ensembl chr 1:166,893,734...166,898,252
|
|
|
G |
Tubb3 |
tubulin, beta 3 class III |
|
ISO |
ClinVar Annotator: match by term: FEOM3 LOCUS ClinVar Annotator: match by term: Fibrosis of extraocular muscles, congenital, 3a, with or without extraocular involvement ClinVar Annotator: match by OMIM:600638 |
OMIM ClinVar |
PMID:2133536 PMID:7724178 PMID:10393037 PMID:12073023 PMID:15223798 PMID:18414213 PMID:20074521 PMID:20829227 PMID:24612975 PMID:25741868 PMID:26775887 PMID:27046833 |
|
NCBI chr19:56,220,759...56,229,813
Ensembl chr19:56,220,755...56,229,813
|
|
|
G |
Kif21a |
kinesin family member 21A |
|
ISO |
ClinVar Annotator: match by OMIM:135700 ClinVar Annotator: match by term: Fibrosis of extraocular muscles, congenital, 3b CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by null |
ClinVar CTD |
PMID:10922204 PMID:14595441 PMID:15223798 PMID:15621876 PMID:15621877 PMID:15827546 PMID:18332320 PMID:19551685 PMID:25741868 |
|
NCBI chr 7:132,069,962...132,200,947
Ensembl chr 7:132,071,116...132,143,470
|
|
|
G |
Col25a1 |
collagen type XXV alpha 1 chain |
|
ISO |
ClinVar Annotator: match by term: Fibrosis of extraocular muscles, congenital, 5 |
ClinVar OMIM |
PMID:25500261 |
|
NCBI chr 2:235,515,364...235,705,448
Ensembl chr 2:235,596,123...235,715,057
|
|
|
G |
Col25a1 |
collagen type XXV alpha 1 chain |
|
ISS |
OMIM:135700 | OMIM:600638 | OMIM:602078 | OMIM:609384 | OMIM:609428 | OMIM:616219 |
MouseDO |
|
|
NCBI chr 2:235,515,364...235,705,448
Ensembl chr 2:235,596,123...235,715,057
|
|
G |
Kif21a |
kinesin family member 21A |
|
ISO ISS |
ClinVar Annotator: match by term: Congenital fibrosis of the extraocular muscles OMIM:135700 | OMIM:600638 | OMIM:602078 | OMIM:609384 | OMIM:609428 | OMIM:616219 |
ClinVar MouseDO |
|
|
NCBI chr 7:132,069,962...132,200,947
Ensembl chr 7:132,071,116...132,143,470
|
|
G |
Phox2a |
paired-like homeobox 2a |
|
ISS |
OMIM:135700 | OMIM:600638 | OMIM:602078 | OMIM:609384 | OMIM:609428 | OMIM:616219 |
MouseDO |
|
|
NCBI chr 1:166,893,734...166,898,252
Ensembl chr 1:166,893,734...166,898,252
|
|
G |
Tuba1a |
tubulin, alpha 1A |
|
ISO |
ClinVar Annotator: match by term: Congenital fibrosis of extraocular muscles |
ClinVar |
PMID:25741868 |
|
NCBI chr 7:140,637,287...140,640,953
Ensembl chr 7:140,637,287...140,640,953
|
|
G |
Tubb3 |
tubulin, beta 3 class III |
|
ISS |
OMIM:135700 | OMIM:600638 | OMIM:602078 | OMIM:609384 | OMIM:609428 | OMIM:616219 |
MouseDO |
|
|
NCBI chr19:56,220,759...56,229,813
Ensembl chr19:56,220,755...56,229,813
|
|
|
G |
Ace |
angiotensin I converting enzyme |
|
IEP |
associated with Polycystic Kidney, Autosomal Recessive;mRNA:increased expression:liver |
RGD |
PMID:20400910 |
RGD:2325215 |
NCBI chr10:94,170,766...94,213,831
Ensembl chr10:94,170,766...94,187,822
|
|
G |
Ifnl3 |
interferon, lambda 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28394349 |
|
NCBI chr 1:85,236,243...85,237,775
Ensembl chr 1:85,236,243...85,237,775
|
|
G |
Pkhd1 |
PKHD1 ciliary IPT domain containing fibrocystin/polyductin |
|
ISO |
DNA:mutations:cds:c.7994T>C, p.(Leu2665Pro),c.8518C>T, p.(Arg2840Cys)(human) |
RGD |
PMID:30600684, PMID:30507656 |
RGD:14700919, RGD:14700992 |
NCBI chr 9:26,164,969...26,736,704
|
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte-associated protein 4 |
susceptibility |
ISO |
DNA:SNP: :-318C>T(human) |
RGD |
PMID:18049163 |
RGD:14398738 |
NCBI chr 9:67,699,397...67,706,068
Ensembl chr 9:67,699,379...67,706,065
|
|
G |
Krt18 |
keratin 18 |
|
ISO |
ClinVar Annotator: match by null |
ClinVar |
PMID:9011570 PMID:12724528 |
|
NCBI chr 7:143,629,455...143,633,131
Ensembl chr 7:143,629,455...143,633,131
|
|
G |
Krt8 |
keratin 8 |
|
ISO |
ClinVar Annotator: match by null |
ClinVar |
PMID:9011570 PMID:11372009 PMID:12724528 |
|
NCBI chr 7:143,596,511...143,603,745
Ensembl chr 7:143,596,511...143,603,803
|
|
|
G |
Cav1 |
caveolin 1 |
|
ISO |
|
RGD |
PMID:18759267 |
RGD:8661773 |
NCBI chr 4:44,597,123...44,630,206
Ensembl chr 4:44,597,123...44,630,200
|
|
G |
Serpine1 |
serpin family E member 1 |
treatment |
ISO |
|
RGD |
PMID:26414805 |
RGD:11343779 |
NCBI chr12:22,641,104...22,651,482
Ensembl chr12:22,641,104...22,651,482
|
|
G |
Stat4 |
signal transducer and activator of transcription 4 |
|
ISO |
|
RGD |
PMID:21360510 |
RGD:8661691 |
NCBI chr 9:54,340,649...54,457,753
Ensembl chr 9:54,287,541...54,484,533
|
|
|
G |
Muc5b |
mucin 5B, oligomeric mucus/gel-forming |
|
ISO |
ClinVar Annotator: match by term: Diffuse interstitial pulmonary fibrosis |
ClinVar |
PMID:21506741 PMID:21506748 PMID:23321605 PMID:23692170 PMID:23695349 PMID:23940607 PMID:24033266 PMID:25926289 PMID:30345907 |
|
NCBI chr 1:214,778,459...214,811,237
Ensembl chr 1:214,778,496...214,810,720
|
|
|
G |
A2m |
alpha-2-macroglobulin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:154,309,426...154,359,138
|
|
G |
Aadac |
arylacetamide deacetylase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:150,146,234...150,157,480
Ensembl chr 2:150,146,234...150,157,480
|
|
G |
Aadat |
aminoadipate aminotransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr16:32,832,001...32,868,680
Ensembl chr16:32,832,061...32,868,702
|
|
G |
Abat |
4-aminobutyrate aminotransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:7,093,406...7,200,439
Ensembl chr10:7,093,405...7,200,499
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16182555 PMID:17072980 |
|
NCBI chr 4:22,339,829...22,517,642
Ensembl chr 4:22,133,521...22,425,515
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:263,554,426...263,612,556
Ensembl chr 1:263,554,453...263,613,252
|
|
G |
Abcc5 |
ATP binding cassette subfamily C member 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr11:84,395,982...84,490,215
Ensembl chr11:84,396,033...84,490,211
|
|
G |
Abcg1 |
ATP binding cassette subfamily G member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr20:9,743,269...9,842,735
Ensembl chr20:9,743,269...9,840,489
|
|
G |
Abcg5 |
ATP binding cassette subfamily G member 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 6:7,935,771...7,961,207
Ensembl chr 6:7,935,771...7,961,207
|
|
G |
Abcg8 |
ATP binding cassette subfamily G member 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 6:7,961,413...7,980,708
Ensembl chr 6:7,961,413...7,980,708
|
|
G |
Ablim3 |
actin binding LIM protein family, member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr18:57,126,534...57,245,965
Ensembl chr18:57,128,399...57,245,666
|
|
G |
Acat1 |
acetyl-CoA acetyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:58,166,990...58,195,884
Ensembl chr 8:58,166,990...58,195,884
|
|
G |
Acbd4 |
acyl-CoA binding domain containing 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:91,186,131...91,200,081
Ensembl chr10:91,187,593...91,196,572
|
|
G |
Ace |
angiotensin I converting enzyme |
severity |
IEP |
mRNA: increased expression:liver (rat) protein:increased activity:plasma (human) mRNA:increased expression:liver (rat) |
RGD |
PMID:19424597, PMID:8445218, PMID:23663763, PMID:24035938 |
RGD:25671449, RGD:25671458, RGD:25671457, RGD:21408579 |
NCBI chr10:94,170,766...94,213,831
Ensembl chr10:94,170,766...94,187,822
|
|
G |
Ace2 |
angiotensin I converting enzyme 2 |
|
IEP |
protein:increased expression:liver mRNA, protein:increased expression, increased activity:liver (rat) |
RGD |
PMID:19793108, PMID:16166274 |
RGD:2316776, RGD:40818265 |
NCBI chr X:32,050,734...32,095,860
Ensembl chr X:32,049,931...32,096,016
|
|
G |
Ache |
acetylcholinesterase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16496349 |
|
NCBI chr12:22,472,358...22,477,052
Ensembl chr12:22,472,358...22,478,753
|
|
G |
Ackr3 |
atypical chemokine receptor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 9:97,355,881...97,367,455
Ensembl chr 9:97,355,924...97,367,445
|
|
G |
Acot9 |
acyl-CoA thioesterase 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr X:43,543,069...43,592,200
Ensembl chr X:43,543,070...43,592,200
|
|
G |
Acox2 |
acyl-CoA oxidase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr15:18,449,304...18,481,472
Ensembl chr15:18,451,144...18,481,470
|
|
G |
Acp5 |
acid phosphatase 5, tartrate resistant |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:23,142,733...23,149,067
Ensembl chr 8:23,142,734...23,148,396
|
|
G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr16:48,937,456...49,003,898
Ensembl chr16:48,937,456...49,003,246
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26435214 PMID:26739621 |
|
NCBI chr 1:252,537,614...252,550,394
Ensembl chr 1:252,537,615...252,550,394
|
|
G |
Actn1 |
actinin, alpha 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 6:103,376,557...103,470,497
Ensembl chr 6:103,375,799...103,470,555
|
|
G |
Ada |
adenosine deaminase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:160,115,840...160,139,947
Ensembl chr 3:160,115,842...160,139,947
|
|
G |
Adam17 |
ADAM metallopeptidase domain 17 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 6:43,400,525...43,448,280
Ensembl chr 6:43,400,528...43,448,280
|
|
G |
Add3 |
adducin 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:273,854,195...273,961,982
Ensembl chr 1:273,854,248...273,961,982
|
|
G |
Adgre1 |
adhesion G protein-coupled receptor E1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 9:9,431,888...9,585,883
Ensembl chr 9:9,431,860...9,585,865
|
|
G |
Adh1 |
alcohol dehydrogenase 1 (class I) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:243,550,655...243,562,243
Ensembl chr 2:243,550,627...243,687,857
|
|
G |
Adh4 |
alcohol dehydrogenase 4 (class II), pi polypeptide |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 |
|
NCBI chr 2:243,702,035...243,720,063
Ensembl chr 2:243,700,784...243,740,899
|
|
G |
Adhfe1 |
alcohol dehydrogenase, iron containing, 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 5:9,403,194...9,429,783
Ensembl chr 5:9,403,196...9,429,859
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:14724832 |
|
NCBI chr11:81,330,845...81,344,488
Ensembl chr11:81,330,293...81,344,488
|
|
G |
Adipor2 |
adiponectin receptor 2 |
severity |
ISO |
|
RGD |
PMID:29237572 |
RGD:24922203 |
NCBI chr 4:151,412,135...151,480,108
Ensembl chr 4:151,414,684...151,428,894
|
|
G |
Adm |
adrenomedullin |
|
IEP ISO |
protein:increased expression:plasma CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15370692 PMID:16610064, PMID:16713642 |
RGD:1625319 |
NCBI chr 1:175,443,189...175,447,260
Ensembl chr 1:175,445,088...175,447,259
|
|
G |
Adora2a |
adenosine A2a receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16783407 |
|
NCBI chr20:14,265,251...14,282,873
Ensembl chr20:14,265,252...14,282,873
|
|
G |
Adora3 |
adenosine A3 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:208,336,909...208,379,217
Ensembl chr 2:208,373,154...208,376,803
|
|
G |
Adra1b |
adrenoceptor alpha 1B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:29,392,762...29,450,644
Ensembl chr10:29,392,762...29,450,644
|
|
G |
Adrb1 |
adrenoceptor beta 1 |
|
IEP |
mRNA, protein:increased expression:liver |
RGD |
PMID:19785950 |
RGD:5129118 |
NCBI chr 1:277,537,585...277,538,985
Ensembl chr 1:277,537,585...277,538,985
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
|
IEP |
mRNA, protein:increased expression:liver |
RGD |
PMID:19785950 |
RGD:5129118 |
NCBI chr18:57,513,792...57,515,834
Ensembl chr18:57,513,793...57,515,834
|
|
G |
Adrb3 |
adrenoceptor beta 3 |
|
IEP |
mRNA, protein:increased expression:liver |
RGD |
PMID:19785950 |
RGD:5129118 |
NCBI chr16:69,003,541...69,006,632
Ensembl chr16:69,003,868...69,006,632
|
|
G |
Aen |
apoptosis enhancing nuclease |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:140,584,328...140,593,749
Ensembl chr 1:140,584,380...140,593,745
|
|
G |
Afm |
afamin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr14:19,078,678...19,132,212
Ensembl chr14:19,078,680...19,132,208
|
|
G |
Afp |
alpha-fetoprotein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 |
|
NCBI chr14:19,141,755...19,159,919
Ensembl chr14:19,141,755...19,159,923
|
|
G |
Agfg1 |
ArfGAP with FG repeats 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 9:88,607,508...88,663,486
Ensembl chr 9:88,607,508...88,662,224
|
|
G |
Agl |
amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:219,788,234...219,843,189
Ensembl chr 2:219,788,234...219,842,986
|
|
G |
Agt |
angiotensinogen |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12667390 |
|
NCBI chr19:57,321,594...57,333,460
Ensembl chr19:57,321,640...57,333,433
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12890498 PMID:25380136, PMID:24619965 |
RGD:10403061 |
NCBI chr17:35,907,102...35,958,136
Ensembl chr17:35,907,108...35,958,077
|
|
G |
Ahnak |
AHNAK nucleoprotein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:225,184,883...225,429,638
Ensembl chr 1:225,184,939...225,215,015
|
|
G |
Aida |
axin interactor, dorsalization associated |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr13:101,698,096...101,724,928
Ensembl chr13:101,698,096...101,724,923
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr20:5,161,350...5,167,176
Ensembl chr20:5,161,333...5,166,448
|
|
G |
Akr1b1 |
aldo-keto reductase family 1 member B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:61,706,866...61,720,959
Ensembl chr 4:61,706,864...61,720,956
|
|
G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr17:69,761,126...69,778,021
Ensembl chr17:69,761,118...69,778,021
|
|
G |
Aktip |
AKT interacting protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr19:17,290,048...17,300,054
Ensembl chr19:17,290,178...17,300,050
|
|
G |
Alb |
albumin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16642209 PMID:17963606 PMID:21163135 |
|
NCBI chr14:19,176,275...19,191,793
Ensembl chr14:19,176,277...19,191,863
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 |
|
NCBI chr 1:238,222,689...238,264,381
Ensembl chr 1:238,222,521...238,264,330
|
|
G |
Aldh1b1 |
aldehyde dehydrogenase 1 family, member B1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15650968 PMID:25380136 |
|
NCBI chr 5:61,382,351...61,387,359
Ensembl chr 5:61,382,351...61,387,358
|
|
G |
Aldh1l1 |
aldehyde dehydrogenase 1 family, member L1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15650968 |
|
NCBI chr 4:123,516,553...123,564,067
Ensembl chr 4:123,516,788...123,557,501
|
|
G |
Aldh1l2 |
aldehyde dehydrogenase 1 family, member L2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:26,375,866...26,425,838
Ensembl chr 7:26,375,866...26,425,108
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15650968 |
|
NCBI chr12:40,466,418...40,498,813
Ensembl chr12:40,466,495...40,498,752
|
|
G |
Amacr |
alpha-methylacyl-CoA racemase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 PMID:25380136 |
|
NCBI chr 2:60,949,276...60,961,342
Ensembl chr 2:60,949,256...60,961,326
|
|
G |
Angpt1 |
angiopoietin 1 |
disease_progression |
IEP |
protein:increased expression:liver |
RGD |
PMID:17935226 |
RGD:1643338 |
NCBI chr 7:81,338,327...81,592,459
Ensembl chr 7:81,342,280...81,592,206
|
|
G |
Angpt2 |
angiopoietin 2 |
|
IEP |
mRNA, protein:increased expression:multiple organs (rat) |
RGD |
PMID:18978178 |
RGD:2314174 |
NCBI chr16:75,966,480...76,016,147
Ensembl chr16:75,966,352...76,016,195
|
|
G |
Angptl3 |
angiopoietin-like 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 5:117,698,590...117,706,729
Ensembl chr 5:117,698,764...117,705,808
|
|
G |
Ano6 |
anoctamin 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:137,142,063...137,335,208
Ensembl chr 7:137,142,170...137,335,208
|
|
G |
Anp32a |
acidic nuclear phosphoprotein 32 family member A |
treatment |
ISO |
|
RGD |
PMID:19054144 |
RGD:10401133 |
NCBI chr 8:67,295,578...67,333,075
Ensembl chr 8:67,295,727...67,333,247
|
|
G |
Anxa1 |
annexin A1 |
|
IEP ISO |
mRNA:increased expression:liver CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136, PMID:8755646 |
RGD:2306954 |
NCBI chr 1:237,893,983...237,910,002
Ensembl chr 1:237,893,966...237,910,012
|
|
G |
Anxa2 |
annexin A2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:75,687,134...75,723,589
Ensembl chr 8:75,687,100...75,723,594
|
|
G |
Anxa3 |
annexin A3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr14:14,371,921...14,426,503
Ensembl chr14:14,364,008...14,426,437
|
|
G |
Anxa4 |
annexin A4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:118,538,775...118,595,591
Ensembl chr 4:118,538,777...118,595,580
|
|
G |
Anxa5 |
annexin A5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:123,162,477...123,194,730
Ensembl chr 2:123,162,461...123,193,130
|
|
G |
Ap1s2 |
adaptor related protein complex 1 subunit sigma 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr X:32,329,883...32,376,301
Ensembl chr X:32,329,598...32,355,307
|
|
G |
Ap3s1 |
adaptor related protein complex 3 subunit sigma 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr18:40,732,472...40,798,064
Ensembl chr18:40,732,480...40,797,761
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:31,699,309...31,784,192
Ensembl chr 7:31,699,885...31,784,192
|
|
G |
Apbb1ip |
amyloid beta precursor protein binding family B member 1 interacting protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr17:90,098,953...90,149,192
Ensembl chr17:90,099,025...90,149,894
|
|
G |
Apmap |
adipocyte plasma membrane associated protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:146,376,828...146,407,259
Ensembl chr 3:146,376,828...146,407,252
|
|
G |
Apoa1 |
apolipoprotein A1 |
|
IDA |
|
RGD |
PMID:2123716 |
RGD:1599161 |
NCBI chr 8:50,525,091...50,526,875
Ensembl chr 8:50,525,091...50,526,875
|
|
G |
Apoa4 |
apolipoprotein A4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:50,536,983...50,539,371
Ensembl chr 8:50,537,009...50,539,376
|
|
G |
Apobec1 |
apolipoprotein B mRNA editing enzyme catalytic subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:155,386,367...155,414,034
Ensembl chr 4:155,386,711...155,401,480
|
|
G |
Apol9a |
apolipoprotein L 9a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:118,927,013...118,933,778
Ensembl chr 7:118,927,008...118,933,812
|
|
G |
App |
amyloid beta precursor protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr11:24,425,013...24,641,872
Ensembl chr11:24,425,005...24,641,858
|
|
G |
Appl1 |
adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr16:2,560,103...2,602,035
Ensembl chr16:2,563,520...2,602,103
|
|
G |
Aqp7 |
aquaporin 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 PMID:25380136 |
|
NCBI chr 5:57,358,297...57,372,332
Ensembl chr 5:57,358,327...57,372,239
|
|
G |
Arg1 |
arginase 1 |
|
IEP |
mRNA, protein:decreased expression:liver (rat) |
RGD |
PMID:11931836 |
RGD:1626298 |
NCBI chr 1:21,525,421...21,537,872
Ensembl chr 1:21,525,421...21,537,863
|
|
G |
Arg2 |
arginase 2 |
|
IEP |
mRNA, protein:increased expression:liver |
RGD |
PMID:11931836 |
RGD:1626298 |
NCBI chr 6:102,311,097...102,338,406
Ensembl chr 6:102,311,116...102,338,520
|
|
G |
Arhgap30 |
Rho GTPase activating protein 30 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr13:89,774,764...89,796,113
Ensembl chr13:89,774,764...89,796,113
|
|
G |
Arhgap9 |
Rho GTPase activating protein 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:70,612,650...70,620,900
Ensembl chr 7:70,612,103...70,620,890
|
|
G |
Arhgdib |
Rho GDP dissociation inhibitor beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:170,913,920...170,932,789
Ensembl chr 4:170,913,923...170,932,618
|
|
G |
Arl11 |
ADP-ribosylation factor like GTPase 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr15:41,639,985...41,645,685
Ensembl chr15:41,643,541...41,645,685
|
|
G |
Arl8a |
ADP-ribosylation factor like GTPase 8A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr13:51,972,974...51,981,976
Ensembl chr13:51,972,974...51,981,976
|
|
G |
Armcx1 |
armadillo repeat containing, X-linked 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr X:105,535,670...105,539,575
Ensembl chr X:105,537,602...105,539,375 Ensembl chr X:105,537,602...105,539,375
|
|
G |
Arpc1b |
actin related protein 2/3 complex, subunit 1B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr12:11,252,300...11,265,849
Ensembl chr12:11,252,296...11,265,865
|
|
G |
Arrb2 |
arrestin, beta 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:57,040,252...57,048,045
Ensembl chr10:57,040,267...57,048,134
|
|
G |
Asah1 |
N-acylsphingosine amidohydrolase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr16:53,998,604...54,030,006
Ensembl chr16:53,998,560...54,040,836
|
|
G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:33,742,876...33,761,106
Ensembl chr 4:33,743,364...33,761,163
|
|
G |
Aspn |
asporin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr17:14,655,958...14,681,355
Ensembl chr17:14,656,009...14,679,409
|
|
G |
Ass1 |
argininosuccinate synthase 1 |
|
IEP |
mRNA:decreased expression:liver (rat) |
RGD |
PMID:19914391 |
RGD:4140452 |
NCBI chr 3:10,327,411...10,375,847
Ensembl chr 3:10,327,414...10,375,826
|
|
G |
Atf3 |
activating transcription factor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr13:109,817,892...109,849,632
Ensembl chr13:109,817,728...109,849,632
|
|
G |
Atp10d |
ATPase phospholipid transporting 10D (putative) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr14:38,475,956...38,575,937
Ensembl chr14:38,477,330...38,575,785
|
|
G |
Atp6v1d |
ATPase H+ transporting V1 subunit D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 6:102,032,271...102,047,754
Ensembl chr 6:102,032,276...102,047,758
|
|
G |
Atrn |
attractin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:123,434,409...123,567,922
Ensembl chr 3:123,434,409...123,567,918
|
|
G |
Axl |
Axl receptor tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:82,550,892...82,580,761
Ensembl chr 1:82,549,420...82,580,761
|
|
G |
B2m |
beta-2 microglobulin |
|
IEP |
protein:increased expression:urine |
RGD |
PMID:18777138 |
RGD:6482712 |
NCBI chr 3:114,087,287...114,093,311
Ensembl chr 3:114,087,287...114,093,309
|
|
G |
B4galt5 |
beta-1,4-galactosyltransferase 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:164,039,731...164,055,561
Ensembl chr 3:164,039,731...164,095,878
|
|
G |
B9d1 |
B9 domain containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:47,784,294...47,794,399
Ensembl chr10:47,785,033...47,792,590 Ensembl chr10:47,785,033...47,792,590
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
|
IEP |
mRNA:increased expression:liver |
RGD |
PMID:11232245 |
RGD:2315709 |
NCBI chr20:5,609,620...5,618,899
Ensembl chr20:5,609,625...5,618,260
|
|
G |
Bbox1 |
gamma-butyrobetaine hydroxylase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:101,425,684...101,474,848
Ensembl chr 3:101,427,055...101,474,890
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
treatment |
IDA IEP |
mRNA:increased expression:liver (rat) |
RGD |
PMID:24218972, PMID:17938867 |
RGD:10054116, RGD:2293129 |
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
|
|
G |
Bcr |
BCR activator of RhoGEF and GTPase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr20:14,421,250...14,546,406
Ensembl chr20:14,421,141...14,545,772
|
|
G |
Bdh1 |
3-hydroxybutyrate dehydrogenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 PMID:25380136 |
|
NCBI chr11:72,577,547...72,619,435
Ensembl chr11:72,578,533...72,614,176
|
|
G |
Bgn |
biglycan |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr X:157,319,042...157,331,204
Ensembl chr X:157,319,046...157,331,204
|
|
G |
Bicd2 |
BICD cargo adaptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr17:15,673,649...15,718,035
Ensembl chr17:15,673,650...15,718,035
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:6,048,590...6,076,828
Ensembl chr 8:6,048,969...6,076,598
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
IEP |
|
RGD |
PMID:17938867 |
RGD:2293129 |
NCBI chr10:106,856,097...106,864,419
Ensembl chr10:106,856,097...106,864,413
|
|
G |
Bloc1s2 |
biogenesis of lysosomal organelles complex-1, subunit 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:263,913,901...263,920,989
Ensembl chr 1:263,913,854...263,920,962
|
|
G |
Blvra |
biliverdin reductase A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:119,552,550...119,577,796
Ensembl chr 3:119,561,290...119,577,806
|
|
G |
Bmf |
Bcl2 modifying factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:110,303,515...110,324,125
Ensembl chr 3:110,306,067...110,324,084
|
|
G |
Bmp4 |
bone morphogenetic protein 4 |
|
IEP |
mRNA, protein:increased expression:liver |
RGD |
PMID:16447265 |
RGD:1643229 |
NCBI chr15:20,776,060...20,791,013
Ensembl chr15:20,776,054...20,822,740
|
|
G |
Bmp7 |
bone morphogenetic protein 7 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:17127702 |
|
NCBI chr 3:170,879,972...170,955,820
Ensembl chr 3:170,879,973...170,955,399
|
|
G |
C1qa |
complement C1q A chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 5:155,261,254...155,264,101
Ensembl chr 5:155,261,250...155,264,143
|
|
G |
C1qb |
complement C1q B chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 5:155,246,444...155,251,995
Ensembl chr 5:155,246,447...155,252,003
|
|
G |
C1qc |
complement C1q C chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 5:155,255,013...155,258,631
Ensembl chr 5:155,255,005...155,258,392
|
|
G |
C5ar1 |
complement C5a receptor 1 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136, PMID:15995705 |
RGD:1600592 |
NCBI chr 1:78,186,777...78,195,132
Ensembl chr 1:78,186,776...78,195,328
|
|
G |
C7 |
complement C7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:54,707,621...54,781,624
Ensembl chr 2:54,709,138...54,777,729
|
|
G |
C8g |
complement C8 gamma chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:2,724,616...2,727,616
Ensembl chr 3:2,724,616...2,727,616
|
|
G |
Ca3 |
carbonic anhydrase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 PMID:25380136 |
|
NCBI chr 2:88,126,519...88,136,063
Ensembl chr 2:88,126,667...88,135,410
|
|
G |
Ca5a |
carbonic anhydrase 5A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr19:54,731,829...54,761,697
Ensembl chr19:54,731,859...54,761,670
|
|
G |
Camk2d |
calcium/calmodulin-dependent protein kinase II delta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:230,900,907...231,132,207
Ensembl chr 2:230,901,126...231,132,039
|
|
G |
Capg |
capping actin protein, gelsolin like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:100,395,693...100,419,447
Ensembl chr 4:100,407,658...100,419,446
|
|
G |
Casp1 |
caspase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:2,605,743...2,614,637
Ensembl chr 8:2,604,962...2,614,631
|
|
G |
Casp12 |
caspase 12 |
|
IEP ISO |
protein:increased expression:liver CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136, PMID:16092975 |
RGD:2311470 |
NCBI chr 8:2,658,892...2,686,160
Ensembl chr 8:2,659,865...2,686,160
|
|
G |
Casp4 |
caspase 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:2,616,391...2,651,682
Ensembl chr 8:2,635,851...2,651,652
|
|
G |
Casp7 |
caspase 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:277,190,557...277,242,779
Ensembl chr 1:277,190,964...277,242,774
|
|
G |
Cav1 |
caveolin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:44,597,123...44,630,206
Ensembl chr 4:44,597,123...44,630,200
|
|
G |
Ccdc126 |
coiled-coil domain containing 126 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:78,982,022...79,003,052
Ensembl chr 4:78,981,987...79,003,053
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
treatment |
IEP ISO |
CTD Direct Evidence: marker/mechanism human gene in rat model |
CTD |
PMID:15492853, PMID:19144177, PMID:28437891, PMID:15492853 |
RGD:2307001, RGD:14995945, RGD:8549576 |
NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
treatment disease_progression severity |
ISO |
CTD Direct Evidence: marker/mechanism mRNA,protein:increased expression:liver |
CTD |
PMID:25380136, PMID:22574195, PMID:25617348, PMID:20978355, PMID:20978355 |
RGD:14995337, RGD:14995329, RGD:14995328, RGD:14995328 |
NCBI chr10:70,739,764...70,744,303
Ensembl chr10:70,739,800...70,744,315
|
|
G |
Ccl6 |
C-C motif chemokine ligand 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:70,798,118...70,802,750
Ensembl chr10:70,797,124...70,802,782
|
|
G |
Ccl7 |
C-C motif chemokine ligand 7 |
|
IEP |
|
RGD |
PMID:17719030 |
RGD:6483766 |
NCBI chr10:69,423,083...69,424,933
Ensembl chr10:69,423,086...69,424,979
|
|
G |
Ccn2 |
cellular communication network factor 2 |
|
IEP ISO |
mRNA:increased expression:liver (rat) CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136, PMID:19856102 |
RGD:2314367 |
NCBI chr 1:21,851,657...21,854,773
Ensembl chr 1:21,851,660...21,854,773
|
|
G |
Ccn4 |
cellular communication network factor 4 |
|
IEP |
|
RGD |
PMID:24600972 |
RGD:10003105 |
NCBI chr 7:107,695,227...107,723,759
Ensembl chr 7:107,695,215...107,723,772
|
|
G |
Ccna2 |
cyclin A2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:123,274,727...123,282,266
Ensembl chr 2:123,275,881...123,282,214
|
|
G |
Ccnb2 |
cyclin B2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:76,847,972...76,861,165
|
|
G |
Ccng1 |
cyclin G1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:25,903,925...25,910,298
Ensembl chr10:25,903,911...25,910,325
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
treatment |
ISO |
mRNA,protein:increased expression:liver |
RGD |
PMID:19603542, PMID:19603542 |
RGD:14401743, RGD:14401743 |
NCBI chr 8:133,192,398...133,215,599
Ensembl chr 8:133,197,032...133,215,614
|
|
G |
Cd163 |
CD163 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:156,752,063...156,785,467
Ensembl chr 4:156,752,082...156,785,467
|
|
G |
Cd200r1 |
CD200 receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr11:60,848,161...60,882,470
Ensembl chr11:60,848,131...60,882,379
|
|
G |
Cd24 |
CD24 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr20:48,335,540...48,340,847
Ensembl chr20:48,335,540...48,340,846
|
|
G |
Cd276 |
Cd276 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:63,312,060...63,350,411
Ensembl chr 8:63,318,019...63,350,269
|
|
G |
Cd36 |
CD36 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:14,150,309...14,191,498
Ensembl chr 4:14,001,761...14,249,749
|
|
G |
Cd38 |
CD38 molecule |
|
IEP ISO |
mRNA, protein:increased expression:liver CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136, PMID:16343077 |
RGD:2307239 |
NCBI chr14:71,714,768...71,754,990
Ensembl chr14:71,715,269...71,754,672
|
|
G |
Cd48 |
Cd48 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr13:90,116,601...90,140,371
Ensembl chr13:90,116,843...90,140,371
|
|
G |
Cd53 |
Cd53 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:209,489,279...209,537,098
Ensembl chr 2:209,489,279...209,537,087
|
|
G |
Cd5l |
Cd5 molecule-like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:186,685,104...186,696,117
Ensembl chr 2:186,685,104...186,696,117
|
|
G |
Cd63 |
Cd63 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:3,320,250...3,335,583
Ensembl chr 7:3,320,103...3,335,582
|
|
G |
Cd68 |
Cd68 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:56,268,726...56,270,605
Ensembl chr10:56,268,720...56,270,640
|
|
G |
Cd7 |
Cd7 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:110,229,931...110,232,812
Ensembl chr10:110,229,922...110,232,843
|
|
G |
Cd74 |
CD74 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr18:56,071,420...56,080,851
Ensembl chr18:56,071,478...56,080,849
|
|
G |
Cd83 |
CD83 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr17:24,416,651...24,435,790
Ensembl chr17:24,416,651...24,435,790
|
|
G |
Cd86 |
CD86 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr11:67,060,305...67,117,990
Ensembl chr11:67,082,193...67,118,795
|
|
G |
Cdc42se1 |
CDC42 small effector 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:196,402,837...196,410,664
Ensembl chr 2:196,402,837...196,410,659
|
|
G |
Cdh5 |
cadherin 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr19:1,025,122...1,074,333
Ensembl chr19:1,023,683...1,074,365
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr20:20,576,341...20,591,510
Ensembl chr20:20,576,377...20,591,549
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
|
IEP |
|
RGD |
PMID:16534847 |
RGD:2289284 |
NCBI chr 7:3,124,953...3,132,533
Ensembl chr 7:3,124,954...3,132,457
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
|
IEP |
|
RGD |
PMID:16534847 |
RGD:2289284 |
NCBI chr 7:70,345,971...70,352,689
Ensembl chr 7:70,349,863...70,352,418
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864
|
|
G |
Cdkn2aipnl |
CDKN2A interacting protein N-terminal like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:37,422,647...37,432,082
Ensembl chr10:37,422,647...37,432,081
|
|
G |
Cdkn3 |
cyclin-dependent kinase inhibitor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr15:23,553,171...23,564,538
Ensembl chr15:23,553,128...23,564,535
|
|
G |
Cdo1 |
cysteine dioxygenase type 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 |
|
NCBI chr18:40,702,027...40,716,901
Ensembl chr18:40,701,984...40,716,686
|
|
G |
Cebpd |
CCAAT/enhancer binding protein delta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr11:89,008,008...89,009,146
Ensembl chr11:89,008,008...89,009,146
|
|
G |
Cela1 |
chymotrypsin like elastase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 PMID:25380136 |
|
NCBI chr 7:142,305,337...142,318,621
Ensembl chr 7:142,305,338...142,318,620
|
|
G |
Celf2 |
CUGBP, Elav-like family member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr17:75,259,269...75,660,154
Ensembl chr17:75,352,389...75,654,951
|
|
G |
Cemip2 |
cell migration inducing hyaluronidase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:239,397,322...239,474,931
Ensembl chr 1:239,398,043...239,474,931
|
|
G |
Cerk |
ceramide kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:127,015,162...127,058,056
Ensembl chr 7:127,015,162...127,058,056
|
|
G |
Ces2h |
carboxylesterase 2H |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 |
|
NCBI chr19:37,052,555...37,067,176
Ensembl chr19:37,052,556...37,067,156
|
|
G |
Ces3a |
carboxylesterase 3a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 |
|
NCBI chr19:37,070,705...37,079,411
|
|
G |
Cfd |
complement factor D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:12,634,216...12,635,939
Ensembl chr 7:12,634,216...12,635,943
|
|
G |
Cfp |
complement factor properdin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr X:1,311,121...1,316,683
Ensembl chr X:1,311,121...1,316,682
|
|
G |
Chsy1 |
chondroitin sulfate synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:127,010,587...127,071,570
Ensembl chr 1:127,010,588...127,071,570
|
|
G |
Cidea |
cell death-inducing DFFA-like effector a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr18:63,082,861...63,108,450
Ensembl chr18:63,098,144...63,108,051
|
|
G |
Cklf |
chemokine-like factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr19:903,609...914,880
Ensembl chr19:906,411...914,880
|
|
G |
Clec4a3 |
C-type lectin domain family 4, member A3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:155,913,366...155,923,079
Ensembl chr 4:155,913,366...155,923,079
|
|
G |
Clec4f |
C-type lectin domain family 4, member F |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:115,322,300...115,332,021
Ensembl chr 4:115,322,291...115,332,052
|
|
G |
Clic1 |
chloride intracellular channel 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr20:5,040,314...5,049,166
Ensembl chr20:5,040,337...5,049,166
|
|
G |
Clic2 |
chloride intracellular channel 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr20:295,338...310,363
Ensembl chr20:295,250...310,380
|
|
G |
Clp1 |
cleavage factor polyribonucleotide kinase subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:72,125,269...72,137,122
Ensembl chr 3:72,125,273...72,128,973
|
|
G |
Cmtm3 |
CKLF-like MARVEL transmembrane domain containing 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr19:830,874...838,528
Ensembl chr19:830,877...838,099
|
|
G |
Cndp1 |
carnosine dipeptidase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr18:81,466,717...81,512,841
Ensembl chr18:81,466,716...81,499,051
|
|
G |
Cnp |
2',3'-cyclic nucleotide 3' phosphodiesterase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:88,490,798...88,497,357
Ensembl chr10:88,490,798...88,497,356
|
|
G |
Cnpy4 |
canopy FGF signaling regulator 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr12:19,329,027...19,335,126
Ensembl chr12:19,328,957...19,335,119
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17043671 |
|
NCBI chr 5:49,307,584...49,333,064
Ensembl chr 5:49,311,030...49,333,056
|
|
G |
Col12a1 |
collagen type XII alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:87,042,820...87,150,701
Ensembl chr 8:87,040,799...87,158,368
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
treatment |
IEP ISO IDA IMP |
protein:increased expression:liver CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:liver (rat) |
CTD |
PMID:25380136 PMID:26435214 PMID:26739621, PMID:16009107, PMID:22706148, PMID:23958495, PMID:20818932 |
RGD:1601595, RGD:8552768, RGD:8552710, RGD:5688339 |
NCBI chr10:82,745,801...82,762,790
Ensembl chr10:82,745,801...82,762,789
|
|
G |
Col1a2 |
collagen type I alpha 2 chain |
|
IEP ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136, PMID:7512265 |
RGD:7257544 |
NCBI chr 4:31,534,225...31,569,152
Ensembl chr 4:31,534,225...31,569,151
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11788567 PMID:25380136 |
|
NCBI chr 9:52,023,295...52,059,221
Ensembl chr 9:52,023,295...52,059,217
|
|
G |
Col4a1 |
collagen type IV alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr16:83,522,162...83,632,153
Ensembl chr16:83,522,162...83,632,153
|
|
G |
Col4a2 |
collagen type IV alpha 2 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr16:83,386,388...83,522,169
Ensembl chr16:83,387,364...83,438,561
|
|
G |
Col5a1 |
collagen type V alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:6,430,180...6,581,010
Ensembl chr 3:6,430,201...6,578,882
|
|
G |
Col5a2 |
collagen type V alpha 2 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 9:52,091,088...52,238,735
Ensembl chr 9:52,092,511...52,238,564
|
|
G |
Col6a1 |
collagen type VI alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr20:12,657,913...12,676,370
Ensembl chr20:12,658,065...12,675,561
|
|
G |
Col6a2 |
collagen type VI alpha 2 chain |
|
IEP ISO |
Protein:increased expression:liver CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136, PMID:7791542 |
RGD:1600938 |
NCBI chr20:12,773,472...12,801,179
Ensembl chr20:12,773,427...12,801,180
|
|
G |
Colec12 |
collectin sub-family member 12 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr18:867,048...1,054,047
Ensembl chr18:867,048...1,052,606
|
|
G |
Coq10a |
coenzyme Q10A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:2,780,930...2,788,189
Ensembl chr 7:2,780,930...2,786,949
|
|
G |
Cotl1 |
coactosin-like F-actin binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr19:52,465,074...52,499,433
Ensembl chr19:52,465,087...52,499,433
|
|
G |
Cpq |
carboxypeptidase Q |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:71,709,174...72,167,413
Ensembl chr 7:71,709,157...72,167,417
|
|
G |
Cps1 |
carbamoyl-phosphate synthase 1 |
|
IEP ISO |
mRNA:decreased expression:liver CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15650968, PMID:17539997 |
RGD:2303515 |
NCBI chr 9:74,113,437...74,236,274
Ensembl chr 9:74,124,016...74,236,274
|
|
G |
Crot |
carnitine O-octanoyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:22,079,837...22,116,265
Ensembl chr 4:22,081,604...22,116,265
|
|
G |
Crp |
C-reactive protein |
|
IEP |
protein:decreased expression:serum: |
RGD |
PMID:21806828 |
RGD:9491781 |
NCBI chr13:91,080,448...91,081,358
Ensembl chr13:91,054,974...91,093,713
|
|
G |
Crtap |
cartilage associated protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:122,382,613...122,402,209
|
|
G |
Cry1 |
cryptochrome circadian regulator 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:24,534,593...24,634,098
Ensembl chr 7:24,534,615...24,634,097
|
|
G |
Cryab |
crystallin, alpha B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:55,178,543...55,182,546
Ensembl chr 8:55,178,289...55,182,545
|
|
G |
Csad |
cysteine sulfinic acid decarboxylase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 |
|
NCBI chr 7:143,781,520...143,810,880
Ensembl chr 7:143,781,702...143,793,970
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr18:56,414,493...56,458,300
Ensembl chr18:56,414,488...56,458,300
|
|
G |
Csf3 |
colony stimulating factor 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15661404 |
|
NCBI chr10:86,616,785...86,619,160
Ensembl chr10:86,616,785...86,619,157
|
|
G |
Csgalnact1 |
chondroitin sulfate N-acetylgalactosaminyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr16:22,704,318...23,075,071
Ensembl chr16:22,979,444...23,074,798
|
|
G |
Ctse |
cathepsin E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr13:48,426,833...48,449,493
Ensembl chr13:48,426,820...48,449,490
|
|
G |
Ctss |
cathepsin S |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:197,655,780...197,679,768
Ensembl chr 2:197,655,786...197,679,458
|
|
G |
Ctsz |
cathepsin Z |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:172,527,107...172,537,877
Ensembl chr 3:172,527,107...172,537,877
|
|
G |
Cttnbp2nl |
CTTNBP2 N-terminal like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:207,495,056...207,541,808
Ensembl chr 2:207,495,055...207,541,645
|
|
G |
Cxadr |
CXADR, Ig-like cell adhesion molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr11:16,826,269...16,873,564
Ensembl chr11:16,826,399...16,873,562
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr14:18,743,678...18,745,457
Ensembl chr14:18,743,685...18,745,457
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr14:17,210,733...17,212,930
Ensembl chr14:17,210,733...17,212,930
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:149,261,044...149,273,891
Ensembl chr 4:149,261,044...149,273,891
|
|
G |
Cxcl13 |
C-X-C motif chemokine ligand 13 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr14:15,253,146...15,258,221
Ensembl chr14:15,253,125...15,258,207
|
|
G |
Cxcl16 |
C-X-C motif chemokine ligand 16 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:57,060,005...57,064,600
Ensembl chr10:57,060,007...57,064,600
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr14:18,820,168...18,839,659
Ensembl chr14:18,820,168...18,839,595
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr14:17,228,832...17,233,743
Ensembl chr14:17,228,856...17,234,712
|
|
G |
Cyba |
cytochrome b-245 alpha chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr19:55,249,634...55,257,824
Ensembl chr19:55,249,616...55,257,876
|
|
G |
Cybb |
cytochrome b-245 beta chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr X:14,578,330...14,610,049
Ensembl chr X:14,578,264...14,612,547
|
|
G |
Cygb |
cytoglobin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16581302 |
|
NCBI chr10:105,618,325...105,628,091
Ensembl chr10:105,618,326...105,628,091
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 |
|
NCBI chr 1:266,422,127...266,429,947
Ensembl chr 1:266,422,132...266,428,239
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 |
|
NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301
|
|
G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:256,382,861...256,386,729
Ensembl chr 1:256,382,791...256,386,729
|
|
G |
Cyp2a2 |
cytochrome P450, family 2, subfamily a, polypeptide 2 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:83,744,229...83,766,490
Ensembl chr 1:83,653,234...83,766,484
|
|
G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:257,676,172...258,004,428
Ensembl chr 1:257,970,345...258,004,434
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:123,599,264...123,608,436
Ensembl chr 7:123,599,266...123,608,436
|
|
G |
Cyp2t1 |
cytochrome P450, family 2, subfamily t, polypeptide 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:83,965,370...83,969,466
Ensembl chr 1:83,965,608...83,969,559
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
|
ISO EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 PMID:25380136 |
|
NCBI chr12:19,074,288...19,114,491
Ensembl chr12:19,074,583...19,114,399
|
|
G |
Cyp7a1 |
cytochrome P450 family 7 subfamily A member 1 |
treatment |
IMP |
|
RGD |
PMID:15521018 |
RGD:15045602 |
NCBI chr 5:19,358,734...19,368,431
Ensembl chr 5:19,358,734...19,368,431
|
|
G |
Cyria |
CYFIP related Rac1 interactor A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 6:37,555,167...37,661,196
Ensembl chr 6:37,555,182...37,665,064
|
|
G |
Cyrib |
CYFIP related Rac1 interactor B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:104,514,566...104,641,875
Ensembl chr 7:104,516,391...104,556,419
|
|
G |
Cystm1 |
cysteine-rich transmembrane module containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr18:29,165,206...29,233,351
Ensembl chr18:29,191,731...29,232,978
|
|
G |
Dag1 |
dystroglycan 1 |
|
IEP |
mRNA:increased expression:liver |
RGD |
PMID:12177244 |
RGD:2314895 |
NCBI chr 8:116,980,501...116,993,182
Ensembl chr 8:116,980,497...116,993,193
|
|
G |
Dao |
D-amino-acid oxidase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr12:48,353,691...48,373,647
Ensembl chr12:48,354,196...48,365,784
|
|
G |
Dbh |
dopamine beta-hydroxylase |
|
IEP |
mRNA:decreased expression:superior mesenteric artery (rat) |
RGD |
PMID:18457899 |
RGD:5129683 |
NCBI chr 3:5,709,236...5,731,895
Ensembl chr 3:5,709,236...5,731,898
|
|
G |
Dbndd2 |
dysbindin domain containing 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:160,933,833...160,938,468
Ensembl chr 3:160,935,709...160,938,467
|
|
G |
Dcxr |
dicarbonyl and L-xylulose reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:109,906,119...109,909,696
Ensembl chr10:109,906,815...109,909,715
|
|
G |
Ddc |
dopa decarboxylase |
|
IEP ISO |
mRNA:decreased expression:superior mesenteric artery (rat) CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136, PMID:18457899 |
RGD:5129683 |
NCBI chr14:91,905,919...91,996,816
Ensembl chr14:91,905,919...91,996,774
|
|
G |
Depdc7 |
DEP domain containing 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:94,665,714...94,687,013
Ensembl chr 3:94,665,717...94,686,989
|
|
G |
Dhrs3 |
dehydrogenase/reductase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 5:162,809,090...162,843,385
Ensembl chr 5:162,808,646...162,843,383
|
|
G |
Dhrs7 |
dehydrogenase/reductase 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 6:95,522,577...95,541,393
Ensembl chr 6:95,522,577...95,541,393
|
|
G |
Dhtkd1 |
dehydrogenase E1 and transketolase domain containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr17:76,306,585...76,358,058
Ensembl chr17:76,306,585...76,358,058
|
|
G |
Dio1 |
iodothyronine deiodinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 PMID:25380136 |
|
NCBI chr 5:126,894,837...126,911,532
Ensembl chr 5:126,895,286...126,911,520
|
|
G |
Dipk2a |
divergent protein kinase domain 2A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:102,140,713...102,159,828
Ensembl chr 8:102,088,505...102,159,828
|
|
G |
Dock10 |
dedicator of cytokinesis 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 9:86,424,638...86,571,854 NCBI chr 9:86,312,470...86,423,054
Ensembl chr 9:86,312,501...86,571,870
|
|
G |
Dock7 |
dedicator of cytokinesis 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 5:117,595,194...117,780,844
Ensembl chr 5:117,596,136...117,780,777
|
|
G |
Dpp7 |
dipeptidylpeptidase 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:2,569,135...2,573,387
Ensembl chr 3:2,569,135...2,573,387
|
|
G |
Dpys |
dihydropyrimidinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:78,769,918...78,847,941
Ensembl chr 7:78,769,807...78,847,974
|
|
G |
Dram1 |
DNA-damage regulated autophagy modulator 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:28,898,647...28,932,641
Ensembl chr 7:28,898,649...28,932,641
|
|
G |
Duox1 |
dual oxidase 1 |
|
ISO |
|
RGD |
PMID:20690191 |
RGD:40924637 |
NCBI chr 3:114,251,794...114,286,827
Ensembl chr 3:114,253,637...114,286,802
|
|
G |
Dus1l |
dihydrouridine synthase 1-like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:109,972,018...109,979,113
Ensembl chr10:109,972,037...109,979,712
|
|
G |
Dusp16 |
dual specificity phosphatase 16 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:168,470,141...168,551,346
Ensembl chr 4:168,472,412...168,517,177
|
|
G |
Dusp6 |
dual specificity phosphatase 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:41,475,163...41,479,393
Ensembl chr 7:41,475,163...41,479,392
|
|
G |
Dysf |
dysferlin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:115,700,942...115,901,873
Ensembl chr 4:115,712,850...115,901,873
|
|
G |
Ece1 |
endothelin converting enzyme 1 |
|
IEP |
protein:increased expression:liver |
RGD |
PMID:16170464 |
RGD:7243952 |
NCBI chr 5:156,215,469...156,318,652
Ensembl chr 5:156,215,417...156,318,671
|
|
G |
Ect2 |
epithelial cell transforming 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:112,769,385...112,831,476
Ensembl chr 2:112,769,385...112,831,476
|
|
G |
Edn1 |
endothelin 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:12609069 |
|
NCBI chr17:22,136,814...22,143,745
Ensembl chr17:22,137,324...22,143,324
|
|
G |
Egf |
epidermal growth factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:68,820,616...68,895,537
|
|
G |
Eif4e3 |
eukaryotic translation initiation factor 4E family member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:132,068,581...132,111,092
Ensembl chr 4:132,068,598...132,111,079
|
|
G |
Elovl5 |
ELOVL fatty acid elongase 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:85,220,941...85,287,449
Ensembl chr 8:85,259,982...85,285,983
|
|
G |
Emb |
embigin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:49,682,763...49,733,475
Ensembl chr 2:49,682,754...49,732,253
|
|
G |
Emp1 |
epithelial membrane protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:169,161,076...169,181,967
Ensembl chr 4:169,147,243...169,181,966
|
|
G |
Enc1 |
ectodermal-neural cortex 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:28,049,217...28,061,023
Ensembl chr 2:28,049,217...28,061,029
|
|
G |
Enpep |
glutamyl aminopeptidase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:233,667,253...233,743,866
Ensembl chr 2:233,667,254...233,743,866
|
|
G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
treatment |
IEP ISO |
protein:increased activity:serum: CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980, PMID:17850827, PMID:20957682 |
RGD:9685426, RGD:9685427 |
NCBI chr 7:94,479,931...94,563,086
Ensembl chr 7:94,480,396...94,563,001
|
|
G |
Entpd2 |
ectonucleoside triphosphate diphosphohydrolase 2 |
|
IEP |
|
RGD |
PMID:15651265 |
RGD:9685530 |
NCBI chr 3:2,617,795...2,623,818
Ensembl chr 3:2,617,805...2,623,445
|
|
G |
Epb41l2 |
erythrocyte membrane protein band 4.1-like 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:20,881,820...21,067,713
Ensembl chr 1:20,893,995...20,962,526
|
|
G |
Epcam |
epithelial cell adhesion molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 6:11,282,194...11,308,870
Ensembl chr 6:11,281,964...11,298,216
|
|
G |
Erap1 |
endoplasmic reticulum aminopeptidase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:1,410,877...1,449,734
Ensembl chr 2:1,410,934...1,449,733
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30538632 |
|
NCBI chr10:94,588,555...94,682,072
Ensembl chr10:94,588,555...94,681,914
|
|
G |
Extl1 |
exostosin-like glycosyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 5:152,573,755...152,588,956
Ensembl chr 5:152,573,758...152,589,719
|
|
G |
Ezr |
ezrin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:47,287,872...47,331,412
Ensembl chr 1:47,287,874...47,331,412
|
|
G |
F2r |
coagulation factor II (thrombin) receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:26,118,760...26,135,340
Ensembl chr 2:26,118,760...26,135,340
|
|
G |
F5 |
coagulation factor V |
treatment |
IEP |
|
RGD |
PMID:17431769 |
RGD:7394781 |
NCBI chr13:82,479,997...82,535,540
Ensembl chr13:82,479,998...82,535,534
|
|
G |
Fabp2 |
fatty acid binding protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:227,080,912...227,083,654
Ensembl chr 2:227,080,924...227,083,501
|
|
G |
Fabp7 |
fatty acid binding protein 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 PMID:25380136 |
|
NCBI chr20:40,769,624...40,773,156
Ensembl chr20:40,769,586...40,773,349
|
|
G |
Fahd1 |
fumarylacetoacetate hydrolase domain containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:14,214,518...14,215,957
Ensembl chr10:14,214,519...14,215,957
|
|
G |
Fam102b |
family with sequence similarity 102, member B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:211,762,479...211,831,837
Ensembl chr 2:211,772,128...211,831,636
|
|
G |
Fam167b |
family with sequence similarity 167, member B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 5:147,782,692...147,784,345
Ensembl chr 5:147,782,694...147,784,311
|
|
G |
Fam43a |
family with sequence similarity 43, member A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr11:73,676,601...73,679,003
Ensembl chr11:73,676,601...73,678,984
|
|
G |
Fam89a |
family with sequence similarity 89, member A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr19:57,502,308...57,514,896
Ensembl chr19:57,502,308...57,514,896
|
|
G |
Fas |
Fas cell surface death receptor |
|
IEP ISO |
mRNA, protein:increased expression:liver CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30737368, PMID:17105443 |
RGD:2290284 |
NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790
|
|
G |
Fat1 |
FAT atypical cadherin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr16:50,372,150...50,501,716
Ensembl chr16:50,372,128...50,501,921
|
|
G |
Fbn1 |
fibrillin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:117,569,708...117,766,160
Ensembl chr 3:117,569,697...117,766,120
|
|
G |
Fbxo9 |
f-box protein 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:85,388,331...85,413,896
Ensembl chr 8:85,388,333...85,413,484
|
|
G |
Fcer1g |
Fc fragment of IgE receptor Ig |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr13:89,601,894...89,606,326
Ensembl chr13:89,601,896...89,606,326
|
|
G |
Fcgr1a |
Fc fragment of IgG receptor Ia |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:198,430,536...198,439,453
Ensembl chr 2:198,430,530...198,458,041
|
|
G |
Fcgr3a |
Fc fragment of IgG receptor IIIa |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr13:89,385,775...89,396,047
Ensembl chr13:89,385,859...89,396,051
|
|
G |
Fcnb |
ficolin B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:6,617,816...6,626,193
Ensembl chr 3:6,617,751...6,626,284
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16116963 |
|
NCBI chr 2:124,081,072...124,134,133
Ensembl chr 2:124,081,072...124,134,681
|
|
G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
treatment |
IMP |
|
RGD |
PMID:21543745 |
RGD:25440477 |
NCBI chr16:71,265,390...71,319,046
Ensembl chr16:71,266,248...71,319,449
|
|
G |
Fgg |
fibrinogen gamma chain |
|
IEP |
mRNA:increased expression |
RGD |
PMID:17054587 |
RGD:1599810 |
NCBI chr 2:181,987,080...181,994,523
Ensembl chr 2:181,987,217...181,994,514
|
|
G |
Fgl2 |
fibrinogen-like 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:10,323,598...10,329,241
Ensembl chr 4:10,323,607...10,329,241
|
|
G |
Fgr |
FGR proto-oncogene, Src family tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 5:151,172,189...151,199,746
Ensembl chr 5:151,172,206...151,199,745
|
|
G |
Fhl1 |
four and a half LIM domains 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr X:159,112,516...159,172,528
Ensembl chr X:159,112,880...159,172,524
|
|
G |
Fhl2 |
four and a half LIM domains 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 9:49,920,611...49,994,906
Ensembl chr 9:49,920,854...49,950,093
|
|
G |
Fkbp1a |
FKBP prolyl isomerase 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:147,042,944...147,062,725
Ensembl chr 3:147,042,944...147,062,724
|
|
G |
Fli1 |
Fli-1 proto-oncogene, ETS transcription factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:33,541,932...33,661,111
Ensembl chr 8:33,543,258...33,661,049
|
|
G |
Flna |
filamin A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr X:156,460,785...156,487,245
Ensembl chr X:156,463,953...156,487,245
|
|
G |
Fmnl1 |
formin-like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:91,253,757...91,281,422
Ensembl chr10:91,254,058...91,281,418
|
|
G |
Fmnl2 |
formin-like 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:38,400,409...38,677,637
Ensembl chr 3:38,559,914...38,675,878
|
|
G |
Fmo1 |
flavin containing dimethylaniline monoxygenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 PMID:25380136 |
|
NCBI chr13:80,712,885...80,745,095
Ensembl chr13:80,712,882...80,745,347
|
|
G |
Fn1 |
fibronectin 1 |
treatment |
IEP IMP |
mRNA:increased expression:liver: mRNA:altered expression:liver (rat) |
RGD |
PMID:19914391, PMID:15980055 |
RGD:4140452, RGD:1625201 |
NCBI chr 9:78,900,111...78,969,018
Ensembl chr 9:78,900,103...78,969,078
|
|
G |
Folr2 |
folate receptor beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:166,915,045...166,933,377
Ensembl chr 1:166,915,045...166,919,302
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
|
|
G |
Foxa2 |
forkhead box A2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:142,383,084...142,387,493
Ensembl chr 3:142,383,278...142,387,481
|
|
G |
Fry |
FRY microtubule binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr12:5,573,729...5,822,874
Ensembl chr12:5,573,729...5,822,874
|
|
G |
Fstl1 |
follistatin-like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr11:65,791,196...65,845,721
Ensembl chr11:65,782,567...65,845,418
|
|
G |
Ftcd |
formimidoyltransferase cyclodeaminase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr20:12,806,957...12,820,466
Ensembl chr20:12,806,957...12,820,466
|
|
G |
Fxyd2 |
FXYD domain-containing ion transport regulator 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:49,710,334...49,717,492
Ensembl chr 8:49,710,477...49,716,955
|
|
G |
Fxyd5 |
FXYD domain-containing ion transport regulator 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:89,464,853...89,474,450
Ensembl chr 1:89,464,860...89,474,252
|
|
G |
Fxyd6 |
FXYD domain-containing ion transport regulator 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:49,676,520...49,703,419
Ensembl chr 8:49,676,540...49,703,419
|
|
G |
Fyn |
FYN proto-oncogene, Src family tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr20:44,436,354...44,630,316
Ensembl chr20:44,436,403...44,630,317
|
|
G |
Fzd8 |
frizzled class receptor 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr17:62,259,910...62,267,239
Ensembl chr17:62,262,129...62,265,113
|
|
G |
G0s2 |
G0/G1switch 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr13:112,004,140...112,005,052
Ensembl chr13:112,004,140...112,005,052
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:89,286,009...89,296,213
Ensembl chr10:89,285,855...89,296,213
|
|
G |
Gab1 |
GRB2-associated binding protein 1 |
|
ISO |
protein:increased tyrosine phosphorylation: : |
RGD |
PMID:25617348 |
RGD:14995329 |
NCBI chr19:30,794,290...30,903,819
Ensembl chr19:30,794,571...30,902,008
|
|
G |
Galc |
galactosylceramidase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 6:122,177,195...122,239,411
Ensembl chr 6:122,178,602...122,239,614
|
|
G |
Gask1b |
golgi associated kinase 1B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:178,678,946...178,751,459
Ensembl chr 2:178,679,041...178,750,668
|
|
G |
Gbp2 |
guanylate binding protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:248,276,795...248,293,784
Ensembl chr 2:248,276,709...248,293,784
|
|
G |
Gbp4 |
guanylate binding protein 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:248,249,232...248,263,104
Ensembl chr 2:248,249,468...248,263,168
|
|
G |
Gc |
GC, vitamin D binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr14:20,267,023...20,302,577
Ensembl chr14:20,266,891...20,302,581
|
|
G |
Gcat |
glycine C-acetyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:120,263,068...120,269,365
Ensembl chr 7:120,263,054...120,269,451
|
|
G |
Gchfr |
GTP cyclohydrolase I feedback regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:110,975,923...110,979,957
Ensembl chr 3:110,975,923...110,979,957
|
|
G |
Gck |
glucokinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 |
|
NCBI chr14:86,149,146...86,191,589
Ensembl chr14:86,148,928...86,190,659
|
|
G |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:236,547,729...236,585,037
Ensembl chr 1:236,580,034...236,585,035
|
|
G |
Get1 |
guided entry of tail-anchored proteins factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr11:36,497,513...36,511,445
Ensembl chr11:36,497,509...36,511,535
|
|
G |
Gfra1 |
GDNF family receptor alpha 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:279,203,046...279,572,789
|
|
G |
Ggh |
gamma-glutamyl hydrolase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 5:34,040,258...34,063,369
Ensembl chr 5:34,040,258...34,063,361
|
|
G |
Ggta1 |
glycoprotein, alpha-galactosyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:14,614,099...14,701,185
Ensembl chr 3:14,614,122...14,644,951
|
|
G |
Gh1 |
growth hormone 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15334695 |
|
NCBI chr10:94,486,204...94,488,181
Ensembl chr10:94,486,205...94,488,180
|
|
G |
Ghr |
growth hormone receptor |
|
IEP ISO |
mRNA, protein:decreased expression:liver CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 PMID:25380136, PMID:12679928 |
RGD:2307378 |
NCBI chr 2:53,149,225...53,413,954
Ensembl chr 2:53,150,370...53,413,638
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr20:37,876,650...37,889,097
Ensembl chr20:37,876,650...37,889,089
|
|
G |
Gja4 |
gap junction protein, alpha 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 5:145,374,688...145,377,221
Ensembl chr 5:145,374,690...145,377,221
|
|
G |
Gk |
glycerol kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr X:54,227,291...54,303,897
Ensembl chr X:54,227,397...54,303,864
|
|
G |
Glipr1 |
GLI pathogenesis-related 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:54,767,828...54,778,823
Ensembl chr 7:54,767,827...54,778,848
|
|
G |
Gls |
glutaminase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 9:54,212,622...54,284,879
Ensembl chr 9:54,212,767...54,284,872
|
|
G |
Gls2 |
glutaminase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:2,605,679...2,621,853
Ensembl chr 7:2,605,719...2,621,852
|
|
G |
Glt8d1 |
glycosyltransferase 8 domain containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr16:7,082,450...7,097,405
Ensembl chr16:7,082,450...7,097,401
|
|
G |
Gmfg |
glia maturation factor, gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:85,312,473...85,322,860
Ensembl chr 1:85,312,528...85,317,968
|
|
G |
Gna14 |
G protein subunit alpha 14 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:235,165,775...235,347,986
Ensembl chr 1:235,166,718...235,347,937
|
|
G |
Gnai2 |
G protein subunit alpha i2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:116,370,730...116,391,337
Ensembl chr 8:116,370,744...116,391,307
|
|
G |
Gngt2 |
G protein subunit gamma transducin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:83,654,321...83,658,601
Ensembl chr10:83,655,460...83,658,589
|
|
G |
Gnpda1 |
glucosamine-6-phosphate deaminase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr18:31,479,117...31,489,154
Ensembl chr18:31,479,117...31,487,671
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 |
|
NCBI chr 1:263,246,248...263,269,762
Ensembl chr 1:263,246,248...263,269,762
|
|
G |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:275,843,823...275,906,880
Ensembl chr 1:275,846,819...275,906,686
|
|
G |
Gpnmb |
glycoprotein nmb |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:78,694,447...78,715,685
Ensembl chr 4:78,694,447...78,715,683
|
|
G |
Gpr68 |
G protein-coupled receptor 68 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 6:124,874,151...124,903,949
Ensembl chr 6:124,874,151...124,876,710
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
treatment |
ISO IEP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980, PMID:22706148 |
RGD:8552768 |
NCBI chr 7:117,759,083...117,761,932
Ensembl chr 7:117,759,083...117,761,931
|
|
G |
Gpx8 |
glutathione peroxidase 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:44,903,337...44,907,046
Ensembl chr 2:44,903,337...44,907,030
|
|
G |
Grk2 |
G protein-coupled receptor kinase 2 |
|
IEP |
protein:increased expression:aorta |
RGD |
PMID:17256744 |
RGD:1625784 |
NCBI chr 1:219,536,220...219,544,329
Ensembl chr 1:219,536,220...219,544,328
|
|
G |
Grn |
granulin precursor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:90,377,103...90,383,207
Ensembl chr10:90,376,933...90,383,205
|
|
G |
Gsn |
gelsolin |
|
IEP ISO |
mRNA, protein:increased expression CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136, PMID:14574581 |
RGD:1599866 |
NCBI chr 3:14,456,106...14,508,922
Ensembl chr 3:14,467,330...14,508,911
|
|
G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 |
|
NCBI chr 8:85,640,081...85,645,621
|
|
G |
Gsta4 |
glutathione S-transferase alpha 4 |
treatment |
IDA |
|
RGD |
PMID:23075396 |
RGD:9685568 |
NCBI chr 8:85,497,557...85,514,732
Ensembl chr 8:85,497,557...85,518,879
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15650968 |
|
NCBI chr 2:210,803,869...210,809,461
Ensembl chr 2:210,803,869...210,809,306
|
|
G |
Gulp1 |
GULP PTB domain containing engulfment adaptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 9:51,263,484...51,538,066
Ensembl chr 9:51,263,622...51,538,072
|
|
G |
Gzma |
granzyme A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:44,968,846...44,981,436
Ensembl chr 2:44,968,765...44,981,458
|
|
G |
Hagh |
hydroxyacyl glutathione hydrolase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:14,215,913...14,230,506
Ensembl chr10:14,216,155...14,230,515
|
|
G |
Hal |
histidine ammonia lyase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:34,326,087...34,356,413
Ensembl chr 7:34,326,087...34,356,413
|
|
G |
Hao1 |
hydroxyacid oxidase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:127,444,900...127,500,709
Ensembl chr 3:127,444,902...127,500,709
|
|
G |
Hao2 |
hydroxyacid oxidase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 PMID:25380136 |
|
NCBI chr 2:200,785,492...200,808,868
Ensembl chr 2:200,778,122...200,808,857
|
|
G |
Hck |
HCK proto-oncogene, Src family tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:148,579,917...148,623,026
Ensembl chr 3:148,579,920...148,623,033
|
|
G |
Hells |
helicase, lymphoid specific |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:257,901,856...257,953,889
Ensembl chr 1:257,766,691...257,949,183 Ensembl chr 1:257,766,691...257,949,183
|
|
G |
Hexim1 |
HEXIM P-TEFb complex subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:91,200,874...91,202,986
Ensembl chr10:91,200,874...91,202,984
|
|
G |
Hgf |
hepatocyte growth factor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:10677585 PMID:12918455 PMID:15793283 PMID:16465399 PMID:16627068 PMID:17714472 PMID:18637143 |
|
NCBI chr 4:15,435,460...15,505,377
Ensembl chr 4:15,433,295...15,505,362
|
|
G |
Hip1 |
huntingtin interacting protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr12:24,180,795...24,315,373
Ensembl chr12:24,180,937...24,315,373
|
|
G |
Hjv |
hemojuvelin BMP co-receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:198,655,437...198,659,318
Ensembl chr 2:198,655,437...198,659,317
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:27,480,224...27,500,654
Ensembl chr 2:27,480,226...27,500,654
|
|
G |
Hmgn5b |
high mobility group nucleosome binding domain 5B |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:124,477,164...124,485,737
Ensembl chr 1:124,477,164...124,485,724
|
|
G |
Hmox1 |
heme oxygenase 1 |
|
IDA ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:16025519 PMID:16610050 PMID:21163135 PMID:25380136, PMID:19554654 |
RGD:4145305 |
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
|
|
G |
Hopx |
HOP homeobox |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr14:33,354,803...33,362,547
Ensembl chr14:33,354,807...33,362,551
|
|
G |
Hoxa3 |
homeobox A3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:82,137,802...82,181,836
Ensembl chr 4:82,138,683...82,141,385
|
|
G |
Hp |
haptoglobin |
|
IEP |
protein:increased expression:serum protein:decreased expression:serum |
RGD |
PMID:16968543, PMID:21806828 |
RGD:1626367, RGD:9491781 |
NCBI chr19:42,096,255...42,100,805
Ensembl chr19:42,097,995...42,100,804
|
|
G |
Hpcal1 |
hippocalcin-like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 6:43,001,920...43,109,083
Ensembl chr 6:43,001,948...43,109,071
|
|
G |
Hpgds |
hematopoietic prostaglandin D synthase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:95,945,356...95,970,666
Ensembl chr 4:95,946,025...95,970,666
|
|
G |
Hpse |
heparanase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15095483 PMID:18458672 |
|
NCBI chr14:10,534,358...10,576,686
Ensembl chr14:10,534,423...10,575,224
|
|
G |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 PMID:25380136 |
|
NCBI chr19:50,246,404...50,317,892
Ensembl chr19:50,246,402...50,317,891
|
|
G |
Hsd17b6 |
hydroxysteroid (17-beta) dehydrogenase 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 |
|
NCBI chr 7:2,412,370...2,431,249
Ensembl chr 7:2,412,363...2,431,197 Ensembl chr13:2,412,363...2,431,197
|
|
G |
Htr2b |
5-hydroxytryptamine receptor 2B |
|
IEP |
protein:increased expression:liver (rat) |
RGD |
PMID:16936262 |
RGD:9743846 |
NCBI chr 9:93,112,781...93,130,135
Ensembl chr 9:93,112,805...93,125,014
|
|
G |
Hykk |
hydroxylysine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:59,507,975...59,531,745
Ensembl chr 8:59,507,990...59,529,366
|
|
G |
Icam2 |
intercellular adhesion molecule 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:94,569,889...94,581,218
Ensembl chr10:94,569,890...94,576,512
|
|
G |
Id2 |
inhibitor of DNA binding 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:17127702 |
|
NCBI chr 6:44,360,077...44,361,908
Ensembl chr 6:44,348,501...44,363,915
|
|
G |
Id4 |
inhibitor of DNA binding 4, HLH protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr17:16,692,557...16,695,126
Ensembl chr17:16,692,557...16,695,126
|
|
G |
Ido1 |
indoleamine 2,3-dioxygenase 1 |
severity |
ISO |
protein:increased expression:serum (mouse) |
RGD |
PMID:28465467, PMID:28465467 |
RGD:39939037, RGD:39939037 |
NCBI chr16:72,216,326...72,228,098
Ensembl chr16:72,216,326...72,228,098
|
|
G |
Idua |
alpha-L-iduronidase |
|
IEP |
protein:increased expression:liver |
RGD |
PMID:6875476 |
RGD:12910840 |
NCBI chr14:2,041,828...2,056,762
Ensembl chr14:2,042,411...2,056,762
|
|
G |
Ifi35 |
interferon-induced protein 35 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:89,358,376...89,366,628
Ensembl chr10:89,358,376...89,366,626
|
|
G |
Ifng |
interferon gamma |
|
ISO |
CTD Direct Evidence: therapeutic protein:increased expression:serum (mouse) |
CTD |
PMID:12389079 PMID:15996030 PMID:16953842 PMID:17347453, PMID:28465467 |
RGD:39939037 |
NCBI chr 7:61,337,383...61,341,419
Ensembl chr 7:61,337,381...61,341,419
|
|
G |
Ifngr1 |
interferon gamma receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:15,062,380...15,080,815
Ensembl chr 1:15,062,432...15,080,907
|
|
G |
Ifrd1 |
interferon-related developmental regulator 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 6:60,132,025...60,151,354
Ensembl chr 6:60,132,024...60,151,420
|
|
G |
Igf1 |
insulin-like growth factor 1 |
treatment |
ISO IMP IEP |
CTD Direct Evidence: therapeutic protein:increased expression:liver: |
CTD |
PMID:15591519 PMID:15745444, PMID:16434425, PMID:20198635, PMID:12800242 |
RGD:2317647, RGD:12904923, RGD:10045984 |
NCBI chr 7:28,412,123...28,491,815
Ensembl chr 7:28,412,198...28,486,609
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
|
IEP |
protein:increased expression:liver: |
RGD |
PMID:12800242 |
RGD:10045984 |
NCBI chr 1:128,924,921...129,213,816
Ensembl chr 1:128,924,966...129,206,516
|
|
G |
Igf2bp3 |
insulin-like growth factor 2 mRNA binding protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:78,744,683...78,879,457
Ensembl chr 4:78,746,547...78,879,294
|
|
G |
Igf2r |
insulin-like growth factor 2 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:48,176,095...48,264,482
Ensembl chr 1:48,176,106...48,264,477
|
|
G |
Igfals |
insulin-like growth factor binding protein, acid labile subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:14,240,308...14,243,554
Ensembl chr10:14,240,219...14,243,597
|
|
G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 PMID:25380136 |
|
NCBI chr14:87,448,716...87,453,783
Ensembl chr14:87,448,692...87,453,785
|
|
G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 PMID:25380136 |
|
NCBI chr 9:80,118,029...80,144,804
Ensembl chr 9:80,118,029...80,144,789
|
|
G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr14:87,457,647...87,465,374
Ensembl chr14:87,457,647...87,465,374
|
|
G |
Igfbp7 |
insulin-like growth factor binding protein 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr14:33,010,300...33,070,193
Ensembl chr14:33,010,300...33,070,190
|
|
G |
Igsf6 |
immunoglobulin superfamily, member 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:190,997,029...191,007,503
Ensembl chr 1:190,997,029...191,007,503
|
|
G |
Ikbkg |
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30737368 |
|
NCBI chr X:156,254,187...156,280,046
Ensembl chr X:156,257,173...156,270,748
|
|
G |
Il10 |
interleukin 10 |
treatment |
IDA ISO IMP |
CTD Direct Evidence: therapeutic |
CTD |
PMID:12632514 PMID:15362042 PMID:16097045 PMID:16126171 PMID:16539848 PMID:16552806 PMID:16609999 PMID:16688825 PMID:18251166, PMID:23980370, PMID:24993843 |
RGD:7364982, RGD:11049490 |
NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392
|
|
G |
Il17a |
interleukin 17A |
|
ISO |
protein:increased expression:liver, serum (mouse) |
RGD |
PMID:28465467 |
RGD:39939037 |
NCBI chr 9:26,841,299...26,844,786
Ensembl chr 9:26,841,299...26,844,786
|
|
G |
Il18 |
interleukin 18 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:55,009,666...55,016,286
Ensembl chr 8:54,993,859...55,016,299
|
|
G |
Il18bp |
interleukin 18 binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:167,091,521...167,095,727
Ensembl chr 1:167,091,522...167,093,560
|
|
G |
Il1b |
interleukin 1 beta |
treatment |
IEP ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16085334, PMID:24383550 |
RGD:10450610 |
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
|
|
G |
Il2rb |
interleukin 2 receptor subunit beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:119,701,338...119,716,238
Ensembl chr 7:119,701,251...119,716,238
|
|
G |
Il2rg |
interleukin 2 receptor subunit gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr X:71,165,378...71,169,078
Ensembl chr X:71,162,585...71,169,865
|
|
G |
Il33 |
interleukin 33 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:248,112,611...248,147,030
Ensembl chr 1:248,132,090...248,147,029
|
|
G |
Il4 |
interleukin 4 |
|
ISO |
protein:decreased expression:serum (mouse) |
RGD |
PMID:28465467 |
RGD:39939037 |
NCBI chr10:38,963,979...38,969,531
Ensembl chr10:38,963,979...38,969,531
|
|
G |
Il6 |
interleukin 6 |
treatment |
IEP ISO |
mRNA:increased expression:liver (mouse) |
RGD |
PMID:24383550, PMID:28465467 |
RGD:10450610, RGD:39939037 |
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
|
|
G |
Il7r |
interleukin 7 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
|
|
G |
Ilk |
integrin-linked kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16941698 |
|
NCBI chr 1:170,578,941...170,585,192
Ensembl chr 1:170,578,889...170,585,189
|
|
G |
Inhbc |
inhibin subunit beta C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:70,648,005...70,661,475
Ensembl chr 7:70,646,519...70,661,891
|
|
G |
Inhbe |
inhibin subunit beta E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 PMID:25380136 |
|
NCBI chr 7:70,641,423...70,642,848
Ensembl chr 7:70,640,075...70,643,169
|
|
G |
Inmt |
indolethylamine N-methyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:85,381,907...85,386,203
Ensembl chr 4:85,381,889...85,386,231
|
|
G |
Inpp5d |
inositol polyphosphate-5-phosphatase D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 9:94,745,220...94,850,778
Ensembl chr 9:94,745,217...94,850,771
|
|
G |
Inppl1 |
inositol polyphosphate phosphatase-like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:166,898,177...166,912,524
Ensembl chr 1:166,899,894...166,912,524
|
|
G |
Ins2 |
insulin 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:26806094 |
|
NCBI chr 1:215,856,967...215,858,034
Ensembl chr 1:215,856,971...215,858,034
|
|
G |
Insig2 |
insulin induced gene 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr13:37,264,818...37,292,718
Ensembl chr13:37,266,312...37,287,458
|
|
G |
Iqgap1 |
IQ motif containing GTPase activating protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:142,525,041...142,615,673
Ensembl chr 1:142,525,046...142,615,673
|
|
G |
Irf8 |
interferon regulatory factor 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr19:54,314,859...54,336,643
Ensembl chr19:54,314,865...54,336,640
|
|
G |
Isg20 |
interferon stimulated exonuclease gene 20 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:140,602,553...140,608,892
Ensembl chr 1:140,601,791...140,608,946
|
|
G |
Isyna1 |
inositol-3-phosphate synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr16:20,589,497...20,592,333
Ensembl chr16:20,589,481...20,592,449
|
|
G |
Itga2b |
integrin subunit alpha 2b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:90,397,960...90,416,550
Ensembl chr10:90,398,132...90,415,070
|
|
G |
Itgal |
integrin subunit alpha L |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:198,744,053...198,781,745
Ensembl chr 1:198,744,050...198,781,750
|
|
G |
Itgb1 |
integrin subunit beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr19:61,677,512...61,725,537
Ensembl chr19:61,677,542...61,725,535
|
|
G |
Itgb2 |
integrin subunit beta 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr20:11,777,773...11,815,647
Ensembl chr20:11,777,783...11,815,647
|
|
G |
Itgb3 |
integrin subunit beta 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:92,667,869...92,783,413
Ensembl chr10:92,667,869...92,783,410
|
|
G |
Itgb6 |
integrin subunit beta 6 |
|
IMP ISO |
mRNA, protein:increased expression:liver CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18221819, PMID:18538673 |
RGD:2302244 |
NCBI chr 3:46,652,624...46,775,362
Ensembl chr 3:46,652,623...46,726,958
|
|
G |
Ivd |
isovaleryl-CoA dehydrogenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:110,669,355...110,689,789
Ensembl chr 3:110,669,312...110,690,173
|
|
G |
Iyd |
iodotyrosine deiodinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:40,086,513...40,100,966
Ensembl chr 1:40,086,470...40,101,840
|
|
G |
Jak2 |
Janus kinase 2 |
|
IEP ISO |
protein:increased expression, increased tyrosine phosphorylation:liver CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136, PMID:24619965 |
RGD:10403061 |
NCBI chr 1:247,398,667...247,457,521
Ensembl chr 1:247,398,598...247,458,509
|
|
G |
Jdp2 |
Jun dimerization protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 6:109,464,910...109,505,591
Ensembl chr 6:109,466,060...109,505,161
|
|
G |
Kank1 |
KN motif and ankyrin repeat domains 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:243,201,073...243,398,531
Ensembl chr 1:243,276,403...243,398,536
|
|
G |
Kcnj8 |
potassium inwardly-rectifying channel, subfamily J, member 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:176,783,287...176,789,143
Ensembl chr 4:176,782,498...176,789,304
|
|
G |
Klf6 |
Kruppel-like factor 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr17:67,887,939...67,945,052
Ensembl chr17:67,887,939...67,945,037
|
|
G |
Kmo |
kynurenine 3-monooxygenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr13:93,684,324...93,715,378
Ensembl chr13:93,684,437...93,716,227
|
|
G |
Kng2 |
kininogen 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:18054572 |
|
NCBI chr11:81,509,185...81,516,759
|
|
G |
Krt18 |
keratin 18 |
|
ISO IEP |
CTD Direct Evidence: marker/mechanism protein:increased expression:liver, plasma membrane (rat) |
CTD |
PMID:15999547 PMID:17072980 PMID:18395095 PMID:25380136, PMID:21138630 |
RGD:27226809 |
NCBI chr 7:143,629,455...143,633,131
Ensembl chr 7:143,629,455...143,633,131
|
|
G |
Krt19 |
keratin 19 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:88,055,843...88,060,560
Ensembl chr10:88,055,841...88,060,561
|
|
G |
Krt8 |
keratin 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 PMID:25380136 |
|
NCBI chr 7:143,596,511...143,603,745
Ensembl chr 7:143,596,511...143,603,803
|
|
G |
Ktn1 |
kinectin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr15:24,465,761...24,552,833
Ensembl chr15:24,479,761...24,553,197
|
|
G |
Kynu |
kynureninase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:28,416,926...28,566,939
Ensembl chr 3:28,416,954...28,566,928
|
|
G |
L3hypdh |
trans-L-3-hydroxyproline dehydratase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 6:94,824,112...94,834,908
Ensembl chr 6:94,824,112...94,834,908
|
|
G |
Laptm5 |
lysosomal protein transmembrane 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 5:149,015,793...149,069,719
Ensembl chr 5:149,047,681...149,069,719
|
|
G |
Lbh |
LBH regulator of WNT signaling pathway |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 6:24,154,207...24,184,217
Ensembl chr 6:24,160,226...24,181,866
|
|
G |
Lbp |
lipopolysaccharide binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 PMID:25380136 |
|
NCBI chr 3:154,786,232...154,812,910
Ensembl chr 3:154,786,215...154,813,464
|
|
G |
Lcn2 |
lipocalin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 PMID:25380136 |
|
NCBI chr 3:11,414,189...11,417,534
Ensembl chr 3:11,414,186...11,417,546
|
|
G |
Lcp1 |
lymphocyte cytosolic protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr15:57,170,566...57,277,811
Ensembl chr15:57,221,292...57,277,811
|
|
G |
Lcp2 |
lymphocyte cytosolic protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:18,996,523...19,043,289
Ensembl chr10:18,996,523...19,043,286
|
|
G |
Ldhb |
lactate dehydrogenase B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:176,701,980...176,719,999
Ensembl chr 4:176,701,983...176,720,012
|
|
G |
Lep |
leptin |
disease_progression |
ISO IMP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12586293 PMID:16097051 PMID:29248466, PMID:19065677, PMID:20509998 |
RGD:5128713, RGD:5128589 |
NCBI chr 4:56,337,695...56,351,818
Ensembl chr 4:56,337,695...56,351,818
|
|
G |
Lepr |
leptin receptor |
|
IEP |
protein:increased expression:serum: |
RGD |
PMID:23886859 |
RGD:10412036 |
NCBI chr 5:120,503,475...120,682,281
Ensembl chr 5:120,564,645...120,682,221
|
|
G |
Lgals1 |
galectin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:120,153,184...120,156,290
Ensembl chr 7:120,153,184...120,156,289
|
|
G |
Lgals2 |
galectin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:120,071,122...120,077,612
Ensembl chr 7:120,071,124...120,077,612
|
|
G |
Lgals3 |
galectin 3 |
|
IEP ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16549783 PMID:25380136, PMID:12646584, PMID:16549783 |
RGD:9685223, RGD:9685224 |
NCBI chr15:24,153,602...24,165,537
Ensembl chr15:24,141,651...24,165,537
|
|
G |
Lgalsl |
galectin-like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr14:105,047,915...105,055,421
Ensembl chr14:105,047,919...105,055,421
|
|
G |
Lgmn |
legumain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 6:126,282,246...126,308,207
Ensembl chr 6:126,282,233...126,320,726
|
|
G |
Lhfpl6 |
LHFPL tetraspan subfamily member 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:142,262,236...142,461,980
Ensembl chr 2:142,262,236...142,461,980
|
|
G |
Limk2 |
LIM domain kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr14:83,564,048...83,641,996
Ensembl chr14:83,573,928...83,641,892
|
|
G |
Lin7a |
lin-7 homolog A, crumbs cell polarity complex component |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:49,429,613...49,627,835
Ensembl chr 7:49,385,705...49,656,856
|
|
G |
Lmo2 |
LIM domain only 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:93,909,156...93,931,888
Ensembl chr 3:93,909,156...93,931,871
|
|
G |
LOC100363405 |
hypothetical LOC100363405 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 5:77,265,335...77,294,739
Ensembl chr 5:77,266,842...77,294,765
|
|
G |
LOC102551265 |
phospholipid scramblase 1-like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:99,740,031...99,783,260
Ensembl chr 8:99,680,406...99,783,327
|
|
G |
Lox |
lysyl oxidase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr18:47,500,320...47,577,819
Ensembl chr18:47,500,330...47,577,819
|
|
G |
Loxl2 |
lysyl oxidase-like 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr15:51,276,022...51,365,238
Ensembl chr15:51,303,909...51,365,234
|
|
G |
Lpl |
lipoprotein lipase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr16:22,537,687...22,561,487
Ensembl chr16:22,537,056...22,561,496
|
|
G |
Lpxn |
leupaxin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:229,642,437...229,674,129
Ensembl chr 1:229,642,412...229,674,134
|
|
G |
Lrat |
lecithin retinol acyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:181,896,304...181,905,366
Ensembl chr 2:181,896,305...181,905,300
|
|
G |
Lrp6 |
LDL receptor related protein 6 |
|
ISO |
|
RGD |
PMID:18006602 |
RGD:4110127 |
NCBI chr 4:168,194,054...168,323,962
Ensembl chr 4:168,194,927...168,323,751
|
|
G |
Lrrc28 |
leucine rich repeat containing 28 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:128,486,164...128,604,190
Ensembl chr 1:128,486,166...128,604,188
|
|
G |
Lrrfip1 |
LRR binding FLII interacting protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 9:98,139,484...98,268,148
Ensembl chr 9:98,190,829...98,257,735
|
|
G |
Lta4h |
leukotriene A4 hydrolase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:34,288,333...34,320,243
Ensembl chr 7:34,288,365...34,320,235
|
|
G |
Ltb |
lymphotoxin beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr20:5,184,631...5,186,476
Ensembl chr20:5,184,515...5,186,503
|
|
G |
Ltbp1 |
latent transforming growth factor beta binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 6:21,203,502...21,600,441
Ensembl chr 6:21,203,502...21,600,451
|
|
G |
Lum |
lumican |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:38,820,058...38,826,862
Ensembl chr 7:38,819,771...38,826,862
|
|
G |
Lurap1l |
leucine rich adaptor protein 1-like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 5:98,468,039...98,515,126
Ensembl chr 5:98,469,047...98,515,125
|
|
G |
Ly86 |
lymphocyte antigen 86 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr17:28,104,535...28,191,447
Ensembl chr17:28,104,589...28,191,436
|
|
G |
Ly96 |
lymphocyte antigen 96 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 5:1,972,212...1,989,448
|
|
G |
Magee1 |
MAGE family member E1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25 | |